The PCOS Glossary

Measured to rule out congenital adrenal hyperplasia (CAH), a genetic condition that can mimic PCOS by causing elevated androgens and irregular cycles. If your 17-OHP is elevated, particularly when drawn in the morning, your doctor may refer you to an endocrinologist.

ACTH is produced by the pituitary gland in response to CRH (corticotropin-releasing hormone) from the hypothalamus, and its primary role is to stimulate the adrenal glands to produce cortisol and adrenal androgens including DHEA-S. In women with PCOS, particularly those with an adrenal-dominant presentation, elevated ACTH drive leads to excess adrenal androgen production that is entirely separate from the ovarian androgen excess driven by LH and insulin. Chronic psychological and physiological stress elevates CRH, which raises ACTH, which raises cortisol and adrenal androgens simultaneously. This is one of the most direct mechanisms through which chronic stress worsens androgenic PCOS symptoms. ACTH stimulation testing is sometimes used to investigate congenital adrenal hyperplasia, measuring how the adrenal glands respond to ACTH challenge by measuring 17-hydroxyprogesterone before and after stimulation.

Acupuncture is a practice from Traditional Chinese Medicine (TCM) involving the insertion of very fine needles at specific points along the body's meridian pathways with the intention of restoring the flow of qi (vital energy) and supporting the body's self-regulating capacity. From a biomedical perspective, research suggests acupuncture may influence the hypothalamic-pituitary-ovarian (HPO) axis, reduce sympathetic nervous system activity (the stress response), modulate beta-endorphin levels which affect GnRH pulsatility, and improve blood flow to the ovaries and uterus. A growing body of research, including randomised controlled trials, supports acupuncture as a complementary intervention for PCOS, showing improvements in menstrual regularity, ovulation frequency, androgen levels, and quality of life in some women. It is not a standalone cure, but for women who find pharmaceutical options insufficient or want to complement their existing protocol with a nervous system-regulating, whole-body approach, acupuncture is one of the better-evidenced complementary therapies available. Finding a practitioner who specialises in women's health and gynaecological conditions is important for the best outcomes.

Acute inflammation is a short-term protective response to injury or infection that resolves once the threat is gone. Chronic inflammation is a low-grade, persistent state of immune activation with no clear endpoint. PCOS is associated with chronic inflammation, which worsens insulin resistance, disrupts ovulation, and is driven by factors including poor diet, sleep deprivation, stress, and excess body fat.

A class of plants that help the body adapt to physical and emotional stress by modulating the HPA axis. Adaptogens do not simply sedate or stimulate but support a more measured, resilient stress response. Examples include ashwagandha, rhodiola, and gynostemma. For women with PCOS, choosing an adaptogen that does not raise testosterone is important.

A condition in which the endometrial tissue that normally lines the uterus grows into the muscular wall of the uterus itself (the myometrium), causing the uterine wall to thicken and the uterus to enlarge. The result is often extremely heavy, prolonged, and painful periods, severe cramping, pelvic pressure, and sometimes pain during intercourse. Adenomyosis is distinct from endometriosis, where tissue grows outside the uterus, though the two conditions can and frequently do co-exist. Like endometriosis, adenomyosis is an oestrogen-dependent condition. It is more commonly diagnosed in women in their 30s and 40s and is sometimes only discovered during investigation of unexplained fertility challenges. Hysterectomy is often presented as the only definitive cure, but many women manage symptoms effectively through anti-inflammatory and oestrogen-balancing approaches, progesterone therapy, and dietary interventions before considering surgery.

Antidiuretic hormone (ADH), also called vasopressin, is produced in the hypothalamus and released by the posterior pituitary gland. Its primary role is regulating water balance in the body by signalling the kidneys to retain water when the body is dehydrated or blood pressure falls, concentrating the urine and maintaining blood volume. While ADH is not a direct driver of PCOS, it is relevant to women managing hormonal conditions in several ways. Chronic stress elevates ADH alongside cortisol, contributing to fluid retention, bloating, and raised blood pressure. Progesterone has a natural diuretic effect on ADH activity, which is why low progesterone in PCOS and in the luteal phase of PMDD contributes to bloating and water retention. In perimenopause and menopause, declining oestrogen affects ADH sensitivity, contributing to the fluid regulation changes, night sweats, and temperature dysregulation of the menopausal transition. Adequate hydration itself modulates ADH release, making consistent water intake a genuinely hormonal health practice.

Adipose tissue, commonly known as body fat, is far more than a passive energy store. It is a dynamic and highly active endocrine organ that produces a range of hormones and signalling molecules called adipokines, including leptin, adiponectin, resistin, and TNF-alpha. Adipose tissue also converts androgens into oestrogen through an enzyme called aromatase. In women with PCOS, excess adipose tissue, particularly visceral fat around the abdominal organs, produces elevated leptin (contributing to leptin resistance), elevated inflammatory cytokines (worsening insulin resistance), and excess aromatase activity (converting androgens to oestrogen and contributing to oestrogen dominance). Adiponectin, which improves insulin sensitivity and reduces inflammation, is paradoxically lower in women with more visceral fat. Understanding fat tissue as an active endocrine participant rather than simply a weight issue reframes the relationship between body composition and PCOS in a more clinically accurate and compassionate way.

Two small glands that sit above the kidneys and produce cortisol, adrenaline, and androgens including DHEA-S. In some women with PCOS, the adrenal glands are the primary source of elevated androgens rather than the ovaries. This adrenal subtype of PCOS is often associated with high stress, anxious temperament, and elevated DHEA-S on blood work.

Adrenaline (epinephrine) and noradrenaline (norepinephrine) are catecholamine hormones produced by the adrenal medulla (the inner portion of the adrenal glands) in response to acute stress, fear, or physical exertion, collectively driving the fight-or-flight response. Adrenaline primarily raises heart rate, dilates airways, and redirects blood flow to muscles. Noradrenaline constricts blood vessels and raises blood pressure. Together they mobilise glucose from glycogen stores, causing a rapid blood sugar rise. In the context of PCOS, the relevance is multifaceted. Women with PCOS frequently have a more reactive sympathetic nervous system, meaning their fight-or-flight response fires more readily and takes longer to recover. This chronic sympathetic activation worsens insulin resistance through repeated glucose mobilisation, elevates cortisol through ongoing HPA axis stimulation, and suppresses the parasympathetic state required for ovulation and reproductive function. Noradrenaline also acts as a neurotransmitter in the brain and plays a direct role in GnRH pulsatility, providing yet another pathway through which chronic stress disrupts ovulation. Practices that activate the parasympathetic nervous system including slow breathing, yoga, cold exposure, and mindfulness directly counter the effects of chronic catecholamine elevation.

A powerful antioxidant that improves insulin sensitivity by enhancing glucose uptake in cells. It reduces oxidative stress, which is elevated in PCOS and contributes to inflammation, ovarian dysfunction, and egg quality impairment. Alpha-Lipoic Acid also supports glutathione recycling, making it doubly valuable in PCOS.

The absence of menstruation for 3 or more consecutive months in a woman who previously had periods, or the failure to start menstruating by age 15. In PCOS it reflects prolonged anovulation. It can also be caused by low body weight, excessive exercise, stress, thyroid dysfunction, or elevated prolactin, all of which should be excluded.

A marker of ovarian reserve, meaning how many eggs you have remaining. Women with PCOS often have elevated AMH because they have more small follicles than average. A high AMH is not dangerous but confirms the presence of many antral follicles characteristic of PCOS.

AMPK is an enzyme present in virtually every cell of the body and is often called the master metabolic switch because of the extraordinary breadth of its regulatory effects on cellular energy. It is activated when cellular energy levels fall, specifically when the ratio of AMP to ATP rises, signalling to the cell that energy needs to be generated more efficiently. When AMPK is switched on it triggers a cascade of metabolic changes: it improves insulin sensitivity by increasing glucose uptake into cells, stimulates fat burning by promoting fatty acid oxidation, reduces inflammatory signalling, suppresses mTOR (a growth pathway that is often overactive in insulin-resistant states), and critically drives mitochondrial biogenesis, meaning it stimulates the creation of new mitochondria and improves the efficiency of existing ones. This last effect is central to understanding why AMPK activation produces such broad and lasting metabolic benefits. More and healthier mitochondria means better cellular energy production, improved insulin signalling, and reduced oxidative stress across all tissues. In PCOS, AMPK activity is commonly reduced, which contributes to insulin resistance, impaired ovarian function, and the chronic low-energy state many women with PCOS experience. Natural activators of AMPK include exercise (particularly resistance training and HIIT), caloric restriction, cold exposure, berberine, gynostemma pentaphyllum (one of the most potent natural AMPK activators known), alpha-lipoic acid, and metformin. This mechanistic overlap is precisely why these interventions produce similar and often synergistic benefits in PCOS management.

A broad screening marker for systemic autoimmune conditions including lupus and other connective tissue diseases. PCOS is associated with elevated inflammatory and autoimmune activity, and some women with PCOS carry low-positive ANA titres. Significantly elevated ANA warrants further investigation.

Scalp hair thinning caused by androgens acting on genetically sensitive hair follicles, shortening their growth cycle. In women, this typically presents as diffuse thinning at the crown and widening of the part rather than a receding hairline. It is different from stress-related hair shedding (telogen effluvium), which causes more widespread, temporary loss.

A group of hormones that includes testosterone, DHEA, DHEA-S, and androstenedione. All women produce androgens in small amounts, but in PCOS they are produced in excess. Androgens are responsible for many of the most distressing PCOS symptoms including acne, excess body hair, and hair thinning on the scalp.

A precursor androgen produced by both the ovaries and adrenal glands, sitting one step before testosterone in the hormonal cascade. Elevated androstenedione is common in PCOS and contributes to symptoms of hyperandrogenism. It is a more sensitive marker than testosterone in some women and is included in Dr Cooper's comprehensive panel.

The absence of ovulation. This is one of the defining features of PCOS and the primary reason for irregular or absent periods. Without ovulation there is no egg release, no corpus luteum, no progesterone, and no natural period. Women who are not ovulating regularly may still experience breakthrough bleeding, which can be mistaken for a normal period.

Describes any substance, food, or practice that reduces chronic systemic inflammation. In PCOS, chronic low-grade inflammation worsens insulin resistance and androgen production. Anti-inflammatory foods include fatty fish, berries, leafy greens, olive oil, and turmeric. Anti-inflammatory lifestyle practices include quality sleep, stress management, and regular moderate exercise.

Immune antibodies directed against insulin itself, found in certain autoimmune conditions and occasionally in insulin-resistant states. Their presence can interfere with insulin measurement and points toward an autoimmune component to glucose dysregulation. Included in Dr Cooper's executive panel to complete a thorough autoimmune assessment.

Markers of autoimmune thyroid disease (Hashimoto's thyroiditis). Elevated anti-TPO antibodies indicate the immune system is attacking the thyroid gland. Hashimoto's is significantly more prevalent in women with PCOS and can cause fluctuating thyroid function, fatigue, brain fog, and weight resistance even when TSH appears normal.

One of the most widely used adaptogens in the world, with strong evidence for reducing cortisol, improving stress resilience, supporting thyroid function, and enhancing energy. However, ashwagandha has been shown to raise testosterone levels, which makes it poorly suited for women with PCOS, hirsutism, acne, or any androgen-excess condition. It is a powerful herb but the wrong adaptogen for most women with PCOS. Gynostemma is a safer alternative that provides comparable adaptogenic and metabolic benefits without androgenic effects.

A second autoimmune thyroid marker, measured alongside anti-TPO to give a complete picture of autoimmune thyroid involvement. Some women with Hashimoto's thyroiditis test positive for ATG but not anti-TPO, so measuring both improves detection. Dr Cooper includes both given the high autoimmune overlap in PCOS.

A bioactive compound found in several plants including goldenseal and barberry, with robust evidence for improving insulin sensitivity. Berberine activates AMPK, an enzyme that regulates cellular energy metabolism, producing effects comparable to metformin in some studies. It also has anti-inflammatory and lipid-lowering properties relevant to the metabolic aspects of PCOS.

A North American plant extensively studied for menopausal symptom relief, particularly hot flushes, night sweats, and mood disturbances. Black cohosh acts on oestrogen receptors and serotonin pathways, making it one of the better-evidenced herbal alternatives to hormone replacement therapy for menopausal women. However, because of its oestrogenic activity it is not appropriate for oestrogen-dominant conditions including PCOS with elevated oestrogen, endometriosis, PMDD, uterine fibroids, or hormone-sensitive conditions. Women with a history of hormone-sensitive cancers should also avoid it without medical supervision.

Bone is far more than a structural scaffold. It is an active tissue that participates in metabolic signalling in ways that have only been appreciated relatively recently. Osteocalcin, a protein produced by osteoblasts (bone-building cells), is released into the bloodstream and has been shown to improve insulin sensitivity, support testosterone production, enhance muscle function, and influence brain development and memory. Whether osteocalcin qualifies as a true hormone is still debated in the research community, with some scientists preferring the term osteokine or bone-derived signalling protein, but its systemic metabolic effects are well documented. This means bone health and metabolic health are bidirectionally connected. In women with PCOS, bone health is relevant from multiple angles. Oestrogen is the primary protector of bone density, and while oestrogen is not typically deficient in reproductive-age women with PCOS, the transition into perimenopause and menopause represents a significant bone density risk, particularly when PCOS has been managed with the contraceptive injection (Depo-Provera), which is associated with bone density loss. Vitamin D, magnesium, zinc, and Vitamin K2 (which directs calcium into bone rather than soft tissue) are the key nutritional pillars of bone health in women with PCOS across the lifespan.

A naturally occurring compound found in small amounts in fruits and vegetables, and produced in small quantities by the body. Calcium D-Glucarate supports oestrogen detoxification through a process called glucuronidation, one of the liver's primary pathways for clearing used hormones from the body. It inhibits beta-glucuronidase, an enzyme produced by certain gut bacteria that can reactivate oestrogen that the liver has already packaged for excretion, sending it back into circulation. This recycling effect contributes to oestrogen dominance. For women with PCOS, endometriosis, PMDD, or uterine fibroids where excess oestrogen is a driver, Calcium D-Glucarate supports the body's ability to clear oestrogen efficiently. It is particularly valuable when the gut microbiome is dysbiotic, as this increases beta-glucuronidase activity.

The cervix is the lower, narrow portion of the uterus that connects the uterine cavity to the vaginal canal. It produces cervical mucus whose quality and quantity change dramatically across the menstrual cycle in response to oestrogen and progesterone, making it one of the most informative fertility markers available to women. Under rising oestrogen in the follicular phase approaching ovulation, cervical mucus becomes clear, stretchy, and slippery, similar to raw egg white, facilitating sperm transport toward the egg. After ovulation, progesterone causes the mucus to become thick, cloudy, and impenetrable, creating a natural barrier to sperm. Women with PCOS who are tracking their fertility using the Fertility Awareness Method observe cervical mucus as one of the primary signs of approaching ovulation. The absence of fertile-quality mucus is a useful indicator that ovulation has not occurred in a given cycle.

An essential trace mineral that enhances insulin receptor sensitivity, helping cells respond more efficiently to insulin and reducing the demand placed on the pancreas. Supplementation has been shown to reduce fasting insulin, improve glucose tolerance, and decrease androgen levels in women with PCOS. However, the form of chromium matters enormously. Chromium chloride (found in most cheap supplements) has very poor bioavailability at under 1%. Chromium picolinate is significantly better and widely studied. Chromium polynicotinate (chromium bound to niacin, also called chromium nicotinate) is considered by many researchers to be the most bioavailable and best-tolerated form, as the niacin carrier mirrors the naturally occurring glucose tolerance factor (GTF) chromium complex found in food. Life Source Metabolic Balance uses chromium polynicotinate for this reason. Individuals with insulin resistance and blood sugar dysregulation tend to excrete more chromium in urine, increasing their need for supplementation.

The body's internal 24-hour clock that regulates sleep, hormone release, metabolism, and immune function. Disrupted circadian rhythms from irregular sleep, night shifts, or excessive screen exposure worsen insulin resistance, elevate cortisol, and disrupt the hormonal signals that govern ovulation. Consistent sleep and wake times are one of the highest-leverage lifestyle interventions for PCOS.

An Ayurvedic herb whose active compound, forskolin, activates adenylate cyclase and raises cyclic AMP (cAMP) in cells. This mechanism supports fat metabolism, thyroid function, and has been studied for weight management. Coleus forskohlii also has oestrogenic activity through its effects on oestrogen-sensitive pathways. While it may be useful in certain contexts, it is not recommended for women with oestrogen-dominant conditions including PCOS with oestrogen excess, endometriosis, PMDD, uterine fibroids, or any condition where additional oestrogenic stimulation would be harmful.

A genetic condition affecting adrenal hormone production that can closely mimic PCOS, including causing irregular periods, elevated androgens, and acne. The non-classical form is mild and often not diagnosed until adulthood. It is distinguished from PCOS by a blood test measuring 17-hydroxyprogesterone, particularly when drawn in the early morning.

An injection of medroxyprogesterone acetate (DMPA), a synthetic progestogen, administered every 12 weeks. It works by suppressing ovulation, thinning the endometrial lining, and thickening cervical mucus. The Depo-Provera injection is associated with one of the most prolonged returns to natural fertility of all reversible contraceptive methods, with some women waiting 12 to 18 months or longer for their natural cycles to resume after stopping. It is also associated with significant bone density loss with long-term use, irregular and often unpredictable bleeding, weight gain, depression, and mood changes. Medroxyprogesterone acetate has notable glucocorticoid activity, meaning it can affect the adrenal axis and cortisol response. For women with PCOS who are managing insulin resistance and adrenal androgen excess, this is a clinically relevant consideration.

The copper IUD is a non-hormonal contraceptive device made of plastic and copper wire, inserted into the uterus where it creates a toxic environment for sperm and prevents fertilisation. It is highly effective, long-lasting, and does not involve synthetic hormones, which makes it appealing to women who want to preserve their natural hormonal cycle. However, it is not without significant considerations. Copper is an essential mineral but copper excess is a very real concern. The IUD continuously releases copper ions into the uterine environment, and copper accumulates systemically over time. Elevated copper is associated with oestrogen dominance because copper and oestrogen have a mutually stimulating relationship, excess copper also suppresses zinc, and zinc deficiency worsens androgen excess, immune function, and mood. Women with PCOS who already tend toward zinc insufficiency and oestrogen dominance may find the copper IUD amplifies these imbalances. Excess copper has been linked to anxiety, depression, brain fog, fatigue, hair loss, and worsening PMS and period pain. The common side effect of heavier and more painful periods with the copper IUD is well documented. For women considering a non-hormonal option, monitoring copper and zinc levels before and during use is a sensible precaution.

Coenzyme Q10 is a fat-soluble antioxidant found in every cell of the body, essential for mitochondrial energy production (ATP synthesis) and protection against oxidative stress. It is particularly concentrated in the mitochondria of egg cells (oocytes), where it plays a critical role in egg quality, fertilisation capacity, and early embryo development. Women with PCOS have elevated oxidative stress and measurably lower CoQ10 levels, and supplementation has been shown to improve egg quality, reduce oxidative damage, and support mitochondrial function in reproductive tissues. CoQ10 levels decline naturally with age, making supplementation especially relevant for women with PCOS who are over 35 and trying to conceive. Ubiquinol is the active, reduced form of CoQ10 and is significantly more bioavailable than ubiquinone, particularly in women over 35 whose ability to convert ubiquinone to ubiquinol declines with age.

The structure that forms from a follicle after it releases an egg at ovulation. The corpus luteum produces progesterone to support a potential pregnancy. If no pregnancy occurs it breaks down, progesterone drops, and menstruation begins. In PCOS, because ovulation is infrequent, corpus luteums form rarely, resulting in progesterone deficiency.

The primary stress hormone, produced by the adrenal glands. Chronically elevated cortisol from ongoing stress suppresses ovulation, raises blood sugar, promotes fat storage around the abdomen, and stimulates androgen production. Managing cortisol through sleep, movement, and stress reduction is a foundational part of PCOS treatment.

A marker of systemic inflammation. Women with PCOS often have chronically elevated CRP even without an obvious infection or injury, reflecting the low-grade inflammatory state that characterises the condition. Reducing inflammation through diet and lifestyle can meaningfully improve PCOS symptoms.

The active polyphenol compound in turmeric, with extensive evidence for anti-inflammatory, antioxidant, and insulin-sensitising effects. Curcumin reduces NF-kB signalling, one of the primary inflammatory pathways elevated in PCOS. It has also been shown to reduce testosterone and improve insulin sensitivity in preliminary PCOS research. However, standard curcumin powder has notoriously poor bioavailability, with less than 1% absorbed when taken alone. Two things determine whether a curcumin supplement actually works. First, the concentration of curcuminoids, the active compounds within turmeric. A standardised extract of 95% curcuminoids delivers a meaningful therapeutic dose, whereas generic turmeric powder contains only 2 to 5% curcuminoids. Second, the addition of piperine, the active compound found naturally in black pepper. Piperine is not a form of curcumin but an absorption enhancer that inhibits the liver enzymes that rapidly break curcumin down, increasing its bioavailability by up to 2000%. Life Source Metabolic Balance uses 95% curcuminoids and incorporates piperine specifically to ensure the curcumin is absorbed and active rather than simply passing through.

A medicinal plant from the sedge family, used in Ayurvedic and traditional African medicine for menstrual regulation, pain relief, and digestive support. Cyperus rotundus has demonstrated anti-androgen activity in research, reducing 5-alpha reductase enzyme activity that converts testosterone to its more potent form DHT. This makes it relevant in PCOS for managing hirsutism, acne, and scalp hair loss driven by DHT excess. It also has anti-inflammatory and antispasmodic properties that may support menstrual pain and cycle regularity. Research is ongoing, but its traditional use for female reproductive complaints has sound mechanistic support.

Cysts and fibroids are two of the most commonly confused terms in women's health, and understanding the difference matters because they are entirely different structures, found in different locations, made of different tissue, and managed differently. An ovarian cyst is a fluid-filled sac that forms on or inside the ovary. Most are functional, meaning they arise naturally from the ovulation process and resolve on their own within one to three menstrual cycles without any treatment. The follicular cysts seen in PCOS are technically follicles that failed to release an egg, not true pathological cysts. Less commonly, cysts can be endometriomas (chocolate cysts filled with old blood from endometriosis), dermoid cysts (containing tissue like hair or skin), or cystadenomas. Symptoms when present include pelvic pain, bloating, and pain during intercourse, though many cysts cause no symptoms at all. A fibroid, by contrast, is a solid, non-cancerous growth made of smooth muscle and fibrous connective tissue that develops within or around the wall of the uterus, not the ovary. Fibroids are entirely separate from cysts in origin, composition, and location. They are oestrogen and progesterone sensitive and can range from the size of a pea to the size of a melon. Symptoms include heavy and prolonged periods, pelvic pressure, frequent urination, lower back pain, and fertility challenges depending on their size and position. The simplest distinction to remember is this: cysts are fluid-filled, form on the ovaries, and are usually temporary. Fibroids are solid, form in the uterus, and are permanent unless treated.

Chemical messengers of the immune system that coordinate the inflammatory response. TNF-alpha, IL-6, IL-1alpha, and IL-1beta are all elevated in PCOS and contribute to insulin resistance, disrupted ovulation, and systemic inflammation. Measuring cytokines provides a window into the inflammatory burden driving PCOS beyond what standard CRP captures.

A metabolite of Myo-Inositol that plays a distinct role in insulin signalling within muscle and fat tissue. Research suggests women with PCOS have a defect in converting Myo-Inositol to D-Chiro-Inositol. Supplementing both in the physiological 40:1 ratio addresses this conversion deficit and produces better outcomes than either compound alone.

An androgen produced primarily by the adrenal glands rather than the ovaries. Elevated DHEA-S points to adrenal involvement in your PCOS. This distinction matters because adrenal PCOS may respond differently to treatment than ovarian PCOS.

DHT is the most potent androgen in the human body, formed when testosterone is converted by the enzyme 5-alpha reductase in skin, hair follicles, and other tissues. In women with PCOS, elevated DHT is responsible for the most androgenic symptoms including scalp hair thinning (androgenic alopecia), hirsutism, and cystic acne. DHT binds to androgen receptors in hair follicles and causes them to miniaturise, shortening the growth cycle of scalp hair while simultaneously stimulating coarser growth in androgen-sensitive body areas. 5-alpha reductase inhibitors, including saw palmetto and cyperus rotundus, work by reducing DHT conversion rather than lowering testosterone directly. DHT is not always measured in standard panels but is worth testing when androgenic symptoms are pronounced despite normal testosterone levels.

A dietitian is a regulated, protected healthcare professional who has completed a formal university degree in dietetics including supervised clinical training, and is registered with a professional statutory body. In South Africa this is the Health Professions Council of South Africa (HPCSA). Dietitians are trained to provide medical nutrition therapy, meaning the use of evidence-based dietary interventions to manage diagnosed medical conditions including PCOS, insulin resistance, diabetes, and eating disorders. They are qualified to work within multidisciplinary clinical teams. The title dietitian is legally protected, meaning only those with the appropriate registered qualification may use it.

A traditional Chinese herb long used to support female reproductive health, regulate menstrual cycles, and relieve menstrual cramps. Dong quai has mild oestrogenic activity, meaning it can bind to oestrogen receptors and exert oestrogen-like effects in the body. For women in perimenopause or menopause who are experiencing low oestrogen symptoms, this can be beneficial. However, in oestrogen-dominant conditions including PCOS with elevated oestrogen, endometriosis, PMDD, uterine fibroids, and certain hormone-sensitive conditions, adding oestrogenic herbs may worsen symptoms and is generally not recommended without professional guidance.

An abnormal pattern of blood fats characterised by elevated triglycerides, low HDL cholesterol, and often elevated LDL. This lipid triad is strongly associated with insulin resistance and metabolic syndrome, both of which are common in PCOS. Dyslipidaemia significantly increases cardiovascular risk and is directly improved by addressing insulin resistance through diet, exercise, and targeted supplementation.

A medical doctor who has completed a general medicine degree followed by specialised postgraduate training in the endocrine system, which governs all hormone-producing glands including the thyroid, adrenal glands, pancreas, pituitary, and ovaries. Endocrinologists diagnose and manage conditions including PCOS, thyroid disorders, diabetes, adrenal dysfunction, and pituitary disease. In the context of PCOS, an endocrinologist is the most appropriate specialist when the hormonal picture is complex, when multiple glands appear to be involved, when standard treatments have not worked, or when conditions like congenital adrenal hyperplasia or a pituitary tumour need to be excluded. Not all GPs have deep expertise in PCOS and a referral to an endocrinologist is always appropriate when the diagnosis is uncertain or the condition is not responding to first-line care.

Abnormal thickening of the uterine lining caused by prolonged oestrogen stimulation without the balancing effect of progesterone. Women with PCOS who have infrequent periods are at elevated risk. In most cases it is benign and resolves with progesterone treatment, but atypical hyperplasia carries a small risk of progressing to endometrial cancer.

A chronic inflammatory condition in which tissue similar to the uterine lining (endometrium) grows outside the uterus, most commonly on the ovaries, fallopian tubes, and pelvic peritoneum. This tissue responds to hormonal fluctuations just like the uterine lining, thickening and bleeding each cycle, but with nowhere to exit the body. The result is inflammation, scar tissue (adhesions), and often severe pain. Endometriosis affects approximately 10% of women of reproductive age and is one of the leading causes of infertility and chronic pelvic pain. It is an oestrogen-dependent condition, meaning oestrogen fuels its growth, which is why anti-oestrogenic dietary and lifestyle strategies, progesterone support, and oestrogen detoxification are central to its management. PCOS and endometriosis can co-exist. Women with endometriosis should approach phytoestrogens, oestrogenic herbs such as black cohosh, wild yam, and dong quai, and high soy intake with particular caution.

The inner lining of the uterus that thickens each month in preparation for a fertilised egg. Without ovulation and the progesterone that follows it, the endometrium continues to thicken under oestrogen stimulation without shedding regularly. Over time this can lead to endometrial hyperplasia, which is why regular periods are important for uterine health.

Epigenetics is the study of how gene expression is regulated without changes to the underlying DNA sequence itself. The analogy often used is that DNA is the hardware and epigenetics is the software, determining which genes are switched on or off, amplified or silenced, based on environmental signals including diet, stress, sleep, toxin exposure, and lifestyle. This is profoundly important for women with PCOS because it means that having a genetic predisposition to PCOS does not determine a fixed outcome. The way you live, eat, move, sleep, and manage stress directly influences how your PCOS genes are expressed. Conversely, it also means that the hormonal environment you experienced in the womb, your early childhood nutrition, and your accumulated stress history have all shaped your current hormonal expression in ways that extend beyond simple genetics. The empowering clinical implication is this: consistent, sustained lifestyle and nutritional interventions do not just manage PCOS symptoms. They can measurably alter the epigenetic signals driving the condition at a cellular level. PCOS is not simply your destiny because your mother had it. It is a condition that is profoundly responsive to the environment you create for your body every day.

Exercise is one of the most powerful non-pharmaceutical interventions for PCOS, but the type, intensity, and duration of exercise matters more than most women are told. Resistance training (weight training) is particularly beneficial for PCOS because it builds muscle, which is the primary site of glucose disposal and insulin sensitivity. More muscle mass means the body can clear glucose from the blood more efficiently with less insulin. High-intensity interval training (HIIT) has also shown strong evidence for improving insulin sensitivity in PCOS. However, excessive high-intensity or endurance exercise, particularly when combined with caloric restriction, can activate the stress response, elevate cortisol, further suppress ovulation, and worsen the HPA axis dysregulation common in PCOS. The sweet spot for most women with PCOS is a combination of resistance training 2 to 3 times per week, moderate cardio such as walking, cycling, or swimming, and gentler movement like yoga or Pilates to support nervous system regulation. Post-meal walking for 10 to 15 minutes is one of the simplest and most evidence-backed tools for reducing post-meal glucose spikes in PCOS.

The most common inherited thrombophilia (clotting disorder), caused by a mutation in the Factor V gene that makes blood more likely to clot. Women with PCOS already have elevated cardiovascular risk. The presence of Factor V Leiden significantly increases the risk of deep vein thrombosis and pregnancy complications and informs decisions about hormonal contraception.

Calculated from total testosterone divided by SHBG, multiplied by 100. The FAI gives a more accurate picture of biologically active androgens than testosterone alone. An elevated FAI is one of the clearest biochemical markers of hyperandrogenism in PCOS, even when total testosterone falls within normal limits.

Two slender tubes that connect the ovaries to the uterus, serving as the pathway through which an egg travels after ovulation toward the uterus. Fertilisation of an egg by sperm typically occurs in the fallopian tubes rather than the uterus itself. In PCOS, the fallopian tubes themselves are not usually the primary site of dysfunction, though if ovulation is restored and an egg is released, healthy tube function is essential for natural conception. Endometriosis and pelvic inflammatory disease (PID) can cause scarring and blockage of the fallopian tubes, which is an important distinction from PCOS-related infertility and requires different investigation and management.

Your blood sugar level after fasting for at least 8 hours. A normal fasting glucose does not rule out insulin resistance, which is why fasting insulin should always be measured alongside it. A fasting glucose above 5.6 mmol/L raises the possibility of prediabetes.

Measures the amount of insulin in your blood after an overnight fast. Elevated fasting insulin is a sign of insulin resistance, even when blood sugar appears normal. This is one of the most underutilised tests in PCOS despite insulin resistance being present in up to 70% of women with the condition.

Leptin is the satiety hormone produced by fat cells, and measuring it fasting reveals whether leptin resistance is present. Women with PCOS frequently have elevated fasting leptin with leptin resistance, meaning the brain does not respond normally to satiety signals. This contributes to persistent hunger and difficulty with weight management independent of caloric intake.

A complete count of all blood cell types including red cells, white cells, and platelets. In PCOS, FBE is used to rule out anaemia (which can cause fatigue and hair loss), assess immune function, and establish a baseline. It is the foundational screening test included in Dr Cooper's haematology panel.

Ferritin is the body's iron storage protein and the most sensitive marker of iron deficiency, falling before haemoglobin drops and anaemia becomes apparent. Women with PCOS who have heavy or prolonged periods are at significant risk of iron depletion. Low ferritin causes fatigue, hair loss, brain fog, poor exercise tolerance, and worsened thyroid function, all of which overlap with PCOS symptoms and can make the overall picture more complex. Iron studies include serum iron, ferritin, transferrin saturation, and total iron binding capacity (TIBC). It is worth noting that ferritin is also an acute phase reactant, meaning inflammation can falsely elevate it, masking true iron deficiency. Interpreting ferritin alongside CRP is important to rule out this effect.

The Fertility Awareness Method is a practice of tracking physiological signs of fertility across the menstrual cycle, including basal body temperature (BBT), cervical mucus characteristics, and LH surge detection through urine test strips, to identify fertile and non-fertile days. When practised correctly and consistently it can be used as a non-hormonal contraceptive method or, in the context of PCOS, as a powerful tool for understanding your own cycle patterns and identifying whether ovulation is occurring and when. For women with PCOS who have irregular cycles, FAM takes on particular value because it removes the guesswork around ovulation that makes cycle management and conception planning so challenging. A sustained rise in basal body temperature of 0.2 degrees or more after ovulation confirms that ovulation has occurred. Tracking across multiple cycles reveals patterns, including how cycle length varies, how often ovulation occurs, and how the luteal phase compares cycle to cycle. Apps such as Natural Cycles, Tempdrop, and Kindara support this practice. FAM is not simply a contraceptive choice but a language for understanding your own body, and for women with PCOS this self-knowledge is genuinely transformative.

Non-cancerous growths of muscle and connective tissue in or around the uterine wall. Fibroids are different from ovarian cysts, which form on the ovary. They are not caused by PCOS but share some hormonal risk factors including oestrogen dominance. Symptoms include heavy periods, pelvic pressure, and frequent urination, though many fibroids cause no symptoms at all.

Folate is vitamin B9, but not all forms are equal. The most important distinction is between synthetic folic acid (found in most supplements and fortified foods) and 5-methyltetrahydrofolate (5-MTHF), the biologically active form the body actually uses. To use folic acid, the body must first convert it through several enzymatic steps, including one that requires the MTHFR enzyme. Women who carry MTHFR gene variants (which are extremely common, affecting up to 40% of the population) cannot make this conversion efficiently, meaning standard folic acid supplements may provide little to no benefit. When choosing a folate supplement, always look for 5-MTHF on the label rather than folic acid. This matters profoundly for egg quality, DNA synthesis, homocysteine regulation, and methylation support.

A small fluid-filled sac in the ovary that contains an immature egg. Each month, multiple follicles begin to develop but normally only one matures fully and releases an egg at ovulation. In PCOS, many follicles begin to develop but none reach full maturity, creating the characteristic appearance of many small follicles on ultrasound, often described as a string of pearls.

The portion of testosterone not attached to proteins in the blood, and therefore biologically active. Even when total testosterone is normal, elevated free testosterone can drive symptoms like acne, hair loss, and excess facial hair. This is why your doctor should measure both total and free testosterone.

A hormone produced by the pituitary gland that stimulates the growth of ovarian follicles. In women with PCOS, FSH levels are often normal or low relative to LH, which disrupts ovulation. Your doctor measures this on day 2 or 3 of your cycle for the most accurate reading.

One of the most telling markers in a PCOS workup. A healthy ratio is approximately 1:1. In PCOS it is commonly inverted, with LH significantly higher than FSH. This imbalance drives the ovaries to produce androgens instead of progressing through normal ovulation. Dr Cooper includes this in even the most basic PCOS panel.

The active form of thyroid hormone that drives cellular metabolism. TSH alone does not always reveal the full picture of thyroid function. Some women have normal TSH but low fT3, particularly under chronic stress or after low-calorie dieting, a pattern called low T3 syndrome, which causes fatigue and metabolic slowdown that worsens PCOS.

The storage form of thyroid hormone produced directly by the thyroid gland, converted to the active fT3 in peripheral tissues. Measuring fT4 alongside TSH gives a fuller assessment of thyroid output. Low fT4 with elevated TSH confirms primary hypothyroidism and is included in Dr Cooper's comprehensive PCOS panel.

Functional medicine is an approach to healthcare that seeks to identify and address the root causes of disease rather than managing symptoms in isolation. A functional medicine doctor is typically a medically qualified practitioner who has undertaken additional training through organisations such as the Institute for Functional Medicine (IFM). They use comprehensive testing including advanced hormone panels, microbiome analysis, nutrient status, and genetic markers, and approach treatment through diet, lifestyle, targeted supplementation, and systems biology alongside conventional medicine. For women with PCOS, a functional medicine approach can be particularly valuable because it addresses the interconnected drivers of the condition including insulin resistance, inflammation, gut health, adrenal function, and nutrient deficiencies, rather than treating each symptom in isolation.

Markers of autoimmune insulin-producing cell destruction, associated with type 1 diabetes and LADA (latent autoimmune diabetes in adults). In women presenting with apparent PCOS and insulin resistance, GAD antibodies help distinguish autoimmune diabetes from metabolic insulin resistance, as the two require very different management approaches.

PCOS has a strong hereditary component, with multiple genes contributing to susceptibility rather than a single causative mutation. Variants in genes regulating insulin signalling, androgen synthesis, gonadotropin action, and inflammation all appear to play roles. Having a mother or sister with PCOS significantly increases your risk, though lifestyle factors strongly influence whether and how severely the condition manifests.

A medical doctor who has completed a general medicine degree and postgraduate training in family and community medicine. The GP is typically the first point of contact in the healthcare system and plays a central role in ordering initial investigations, making or referring for a PCOS diagnosis, and coordinating specialist referrals. The depth of knowledge about PCOS varies significantly between GPs, as hormonal and metabolic conditions are not always a focus of standard medical training. Women who feel their concerns are being dismissed or that their management is limited to the contraceptive pill are within their rights to seek a second opinion or request a specialist referral.

Gestational diabetes is a form of glucose intolerance that develops during pregnancy, typically diagnosed between weeks 24 and 28 through an oral glucose tolerance test. It occurs when the hormonal changes of pregnancy, particularly the insulin-antagonising effects of placental hormones, exceed the pancreas's capacity to compensate, resulting in elevated blood sugar. Women with PCOS have 2 to 3 times the risk of developing gestational diabetes compared to women without PCOS, primarily because pre-existing insulin resistance provides far less reserve capacity to manage the additional insulin demand of pregnancy. Gestational diabetes increases the risk of a large baby (macrosomia), caesarean delivery, birth complications, neonatal hypoglycaemia, and significantly raises both the mother's and baby's long-term risk of developing type 2 diabetes. Careful pre-conception optimisation of insulin resistance in women with PCOS is one of the most important steps in reducing gestational diabetes risk.

Glucagon is produced by the alpha cells of the pancreatic islets and acts as the physiological counterpart to insulin. Where insulin lowers blood glucose by facilitating its uptake into cells, glucagon raises blood glucose by stimulating the liver to break down glycogen stores and release glucose into the bloodstream (glycogenolysis) and to produce new glucose from non-carbohydrate sources (gluconeogenesis). Together, insulin and glucagon maintain blood glucose within a narrow range. In women with PCOS and insulin resistance, the insulin-glucagon balance is disrupted. Hyperinsulinaemia suppresses glucagon appropriately after meals but the underlying insulin resistance means cells are not responding effectively, creating a paradox of both high insulin and impaired glucose uptake simultaneously. Glucagon is also relevant in the context of fasting and time-restricted eating, approaches increasingly used in PCOS management, where glucagon rises during fasting periods to maintain blood glucose while insulin falls, creating hormonal conditions that improve insulin sensitivity over time.

A comprehensive test of glucose and insulin handling. After a fasting blood draw, you consume a glucose solution and blood is drawn again at 1 hour and 2 hours. This reveals how effectively your body clears glucose and how much insulin is required to do so. It detects insulin resistance and impaired glucose tolerance that fasting tests alone can miss. Dr Cooper's panel includes post-glucose insulin at both 1 and 2 hours.

The body's master antioxidant, produced by every cell to neutralise free radicals. Both oxidised (inactive) and reduced (active) glutathione are measured in Dr Cooper's panel. A low ratio of reduced to oxidised glutathione indicates antioxidant depletion and significant oxidative stress. Supporting glutathione through NAC, Alpha-Lipoic Acid, and sulphur-rich foods is a therapeutic priority in PCOS.

A measure of how quickly a food raises blood sugar relative to pure glucose. High GI foods cause rapid blood sugar spikes followed by insulin surges, which worsen insulin resistance over time. For women with PCOS, choosing lower GI foods and eating protein and fat alongside carbohydrates helps stabilise blood sugar and reduce insulin demand throughout the day.

Glycaemic load (GL) is a more clinically useful measure than glycaemic index (GI) because it accounts for both the quality and the quantity of carbohydrate in a serving, giving a more accurate picture of how a food will actually affect blood sugar in the real world. A food can have a high glycaemic index but a low glycaemic load if the portion contains very little total carbohydrate. Watermelon is the classic example: it has a high GI of around 72 but a GL of only 4 per standard serving because a serving contains so little carbohydrate. Conversely, a large portion of a moderate GI food can produce a high glycaemic load and a significant insulin response. For women with PCOS managing insulin resistance, understanding glycaemic load is more practical than memorising GI values. A glycaemic load below 10 per meal is considered low, 10 to 20 is moderate, and above 20 is high. Distributing GL across the day through smaller, balanced meals that include protein, fat, and fibre alongside carbohydrates is one of the most effective dietary strategies for stabilising insulin in PCOS.

Released by the hypothalamus in regular pulses to signal the pituitary gland to release FSH and LH. In PCOS, GnRH pulses are often too rapid and too frequent, which preferentially stimulates LH over FSH and contributes to androgen excess and anovulation. Stress, undereating, and excessive exercise all disrupt GnRH pulsatility.

Growth hormone is produced by the pituitary gland in pulsatile bursts, predominantly during deep slow-wave sleep, and stimulates the liver to produce IGF-1. Beyond its role in childhood growth, GH in adult women supports muscle mass maintenance, fat metabolism, bone density, skin collagen, cognitive function, and cellular repair. In PCOS, GH and IGF-1 dynamics are often altered. Some women with PCOS have blunted GH pulses with compensatory elevation of IGF-1, driven by hyperinsulinaemia rather than GH itself. This elevated IGF-1 in the absence of proportionate GH stimulates ovarian androgen production and worsens the hormonal picture. Growth hormone secretion is profoundly dependent on sleep quality, particularly the depth and duration of slow-wave sleep. This is one more mechanistic reason why poor sleep in PCOS is not merely a symptom but an active driver of metabolic and hormonal dysfunction. GH secretion also declines with age and with elevated insulin levels, connecting insulin resistance directly to the accelerated body composition changes and reduced recovery capacity many women with PCOS experience.

The relationship between gut health and PCOS is bidirectional and increasingly recognised as clinically significant. Research consistently shows that women with PCOS have lower gut microbiome diversity, altered bacterial populations, reduced short-chain fatty acid production, and increased intestinal permeability compared to women without PCOS. These gut changes correlate directly with the severity of insulin resistance, androgen levels, and inflammation. The gut also houses the estrobolome, the community of bacteria that metabolise circulating oestrogens, and dysbiosis impairs oestrogen clearance and contributes to oestrogen dominance. Supporting gut health through a diet rich in diverse plant fibres (aiming for 30 or more different plant foods per week), fermented foods including kefir, yoghurt, sauerkraut, and kimchi, reducing ultra-processed foods, and addressing intestinal permeability is not a peripheral concern in PCOS but a central one. The gut-hormone axis is as important as any other system in this condition.

The gut microbiome is the vast ecosystem of trillions of microorganisms including bacteria, fungi, and viruses that inhabit the digestive tract. Far from being separate from reproductive health, the gut microbiome plays a direct role in hormone metabolism, immune regulation, inflammation, and insulin sensitivity. A specific subset of gut bacteria called the estrobolome is responsible for metabolising and regulating circulating oestrogen levels. Dysbiosis (imbalance in the microbiome) impairs oestrogen clearance, contributes to oestrogen dominance, worsens systemic inflammation, and increases intestinal permeability. Women with PCOS have measurably different gut microbiome compositions compared to women without PCOS, with reduced diversity and altered bacterial populations that correlate with the severity of insulin resistance and androgen excess. Supporting the gut microbiome through dietary fibre, fermented foods, prebiotic-rich vegetables, and addressing intestinal permeability is an important and often overlooked dimension of PCOS management.

A medical doctor specialising in the female reproductive system, including the uterus, ovaries, fallopian tubes, cervix, and vagina. Gynaecologists complete a medical degree followed by specialist surgical and obstetric training. They diagnose and manage conditions including PCOS, endometriosis, adenomyosis, uterine fibroids, ovarian cysts, and menstrual disorders, and perform procedures including hysteroscopies and laparoscopies. A reproductive endocrinologist is a gynaecologist with additional subspecialty training in hormones and fertility, making them the most comprehensive specialist for women with PCOS who are trying to conceive. The distinction between a gynaecologist and an endocrinologist matters because PCOS spans both territories, the reproductive system and the broader endocrine and metabolic system.

An adaptogenic herb from East Asia with strong evidence for activating AMPK and improving insulin sensitivity. Unlike ashwagandha, gynostemma does not raise testosterone, making it a superior adaptogen choice for women with PCOS who need stress and metabolic support without androgenic side effects.

The hair follicle is a complex mini-organ embedded in the skin that produces hair through cycling phases of growth (anagen), regression (catagen), and rest (telogen). Hair follicles are exquisitely sensitive to hormonal signals and are one of the most visible sites of androgenic activity in the body. Scalp hair follicles in genetically susceptible women contain androgen receptors that, when activated by DHT, progressively miniaturise the follicle, shortening the anagen growth phase and producing thinner, shorter, and eventually absent hairs, a process called androgenic alopecia. Conversely, follicles in androgen-sensitive areas of the face, chin, chest, and abdomen convert from fine vellus hair to coarse terminal hair under the same DHT stimulation, producing hirsutism. The same hormonal signal therefore causes hair loss in one location and excess hair growth in another. Thyroid hormones, iron, zinc, biotin, and adequate protein are all essential for healthy follicle cycling, which is why deficiencies in any of these produce hair shedding that can compound androgen-driven loss in PCOS.

Hashimoto's thyroiditis is an autoimmune condition in which the immune system produces antibodies that gradually attack and destroy the thyroid gland, leading to progressive loss of thyroid function and hypothyroidism. It is the most common cause of hypothyroidism worldwide and is significantly more prevalent in women than men, with women being up to 10 times more likely to develop it. The connection between Hashimoto's and PCOS is well established. Women with PCOS have a measurably higher prevalence of Hashimoto's than the general population, and the two conditions share common drivers including chronic inflammation, immune dysregulation, insulin resistance, vitamin D deficiency, and gut permeability. Hashimoto's can be present for years before TSH becomes abnormal, which is why Dr Cooper tests both anti-TPO and anti-thyroglobulin (ATG) antibodies as part of every comprehensive PCOS workup. Elevated antibodies signal that the immune attack is already underway even when thyroid hormone levels appear normal. Symptoms of Hashimoto's include fatigue, weight gain, hair loss, brain fog, cold intolerance, constipation, depression, dry skin, and irregular periods, all of which overlap significantly with PCOS and can make each condition harder to identify clearly. Managing Hashimoto's requires addressing the autoimmune component, not just replacing thyroid hormones. An anti-inflammatory diet, optimising Vitamin D, selenium supplementation, addressing gut health, reducing environmental triggers, and managing stress all play meaningful roles in slowing the progression of thyroid antibody activity and supporting overall thyroid health alongside any medical treatment.

Reflects your average blood sugar levels over the past 2 to 3 months by measuring how much glucose has attached to red blood cells. Used to screen for prediabetes and type 2 diabetes, both of which are more common in women with PCOS. A result above 5.7% warrants further investigation.

Often called good cholesterol, HDL transports cholesterol away from the arteries to the liver for processing. Low HDL is a hallmark of insulin resistance and metabolic PCOS. Exercise, healthy fats, and reducing refined carbohydrates raise HDL and improve the overall cardiovascular risk profile.

The growth of coarse, dark, male-pattern hair on the face, chest, abdomen, or back in women. It is caused by androgens acting on hair follicles, converting fine vellus hair to thicker terminal hair. Hirsutism is scored clinically using the Ferriman-Gallwey scale.

A calculated score using fasting glucose and fasting insulin to estimate insulin resistance. A score above 2.5 generally indicates insulin resistance. Ask your doctor to calculate this if they have measured both values, as it gives a clearer picture than either marker alone.

An amino acid that accumulates when the methylation cycle is impaired, particularly in women with MTHFR gene variants and folate or B12 deficiency. Elevated homocysteine is associated with cardiovascular risk, impaired egg quality, and pregnancy complications. It is included in Dr Cooper's methylation panel and is directly addressed by adequate methylfolate and B12 supplementation.

A small flexible rod inserted under the skin of the upper arm that releases a continuous low dose of etonogestrel, a synthetic progestogen, for up to 3 years. The implant works primarily by suppressing ovulation and thickening cervical mucus. Because it delivers a constant systemic dose of synthetic progestogen, it suppresses the HPO axis and prevents ovulation reliably in most women. Etonogestrel has moderate androgenic activity, and irregular bleeding, mood changes, acne, and weight gain are among the most commonly reported side effects, all of which are of particular concern for women with PCOS. For women with PCOS who are already struggling with androgen excess, metabolic dysfunction, and mood dysregulation, the implant introduces a continuous androgenic hormonal signal with no natural cyclical variation, which can be significantly disruptive to wellbeing.

A small T-shaped device inserted into the uterus that releases a low dose of levonorgestrel, a synthetic progestogen, directly into the uterine lining. The hormonal IUD works primarily by thinning the endometrial lining and thickening cervical mucus rather than suppressing ovulation, which means many women continue to ovulate while using it. Because the hormone release is largely local, systemic absorption is lower than with oral contraceptives, though it is not negligible. Levonorgestrel is an androgenic progestogen, meaning it has some testosterone-like activity. For some women with PCOS this worsens acne, hair loss, mood, and androgen symptoms. For others, the reduction in heavy bleeding and endometrial thickening that comes with regular progesterone exposure is genuinely beneficial. The hormonal IUD is generally considered less disruptive to the systemic hormonal environment than the combined pill but it is not hormonally neutral.

The hormonal pathway through which the brain and adrenal glands coordinate the stress response. Chronic activation of the HPA axis from ongoing stress elevates cortisol, suppresses reproductive hormones, and drives adrenal androgen production. Supporting HPA axis health through sleep, adaptogens, and nervous system regulation is foundational in PCOS management.

The clinical or biochemical evidence of excess androgens. Clinically, this presents as acne, hirsutism, or androgenic alopecia. Biochemically, it shows as elevated testosterone, FAI, androstenedione, or DHEA-S on blood work. Hyperandrogenism is one of the three Rotterdam criteria used to diagnose PCOS.

A region of the brain that serves as the master regulator of hormonal function. The hypothalamus releases GnRH to signal the pituitary, which then signals the ovaries. Stress, poor sleep, undereating, and excessive exercise all disrupt hypothalamic signalling, which is why these lifestyle factors have such a direct impact on menstrual regularity.

Surgical removal of the uterus, sometimes including the ovaries and fallopian tubes. It is occasionally suggested as a management option for severe PCOS symptoms, but it is rarely appropriate because PCOS is driven by hormonal and metabolic factors, not by the uterus itself. Removing the uterus does not address the underlying insulin resistance or androgen excess. If the ovaries are also removed, it triggers surgical menopause and its associated risks.

IGF-1 is a hormone produced primarily by the liver in response to growth hormone (GH) signalling, and its name reflects its structural similarity to insulin and its ability to activate insulin receptors. In PCOS, IGF-1 is a significant but often overlooked driver of androgen excess. IGF-1 acts directly on the ovaries, stimulating the theca cells to produce more androgens, and it amplifies the effect of LH on androgen synthesis. Critically, IGF-1 also reduces the liver's production of SHBG, meaning more free testosterone circulates in the blood and drives androgenic symptoms. Insulin and IGF-1 work through overlapping receptor pathways, which is one reason why hyperinsulinaemia worsens PCOS so profoundly: elevated insulin not only stimulates androgen production directly but also elevates IGF-1 activity, compounding the androgenic effect. Dietary patterns that chronically elevate insulin, including high refined carbohydrate and high glycaemic load diets, also tend to elevate IGF-1. Dairy products, particularly milk, are among the most potent dietary stimulators of IGF-1, which is one reason some women with PCOS find that reducing dairy intake improves their androgenic symptoms. High-intensity exercise and growth hormone-stimulating supplements also raise IGF-1, which is worth factoring into a PCOS-specific exercise and supplementation protocol.

PCOS is the most common cause of anovulatory infertility, accounting for approximately 80% of cases. Infertility is defined as the inability to conceive after 12 months of regular unprotected intercourse (or 6 months in women over 35). Subfertility refers to reduced fertility capacity rather than complete inability to conceive. Because PCOS disrupts or prevents ovulation, the primary fertility challenge is the absence of an egg available for fertilisation. The good news is that PCOS-related infertility is highly treatable. First-line interventions include optimising insulin resistance, achieving moderate weight loss where relevant (even 5 to 10% body weight loss can restore ovulation in many women), and targeted supplementation including Myo-Inositol. First-line medical treatment includes letrozole or clomiphene citrate to induce ovulation. IVF is considered when other approaches have not succeeded. Women with PCOS generally have good egg reserve (reflected in elevated AMH) which supports a positive fertility prognosis with appropriate management.

A hormone produced by the pancreas that allows cells to absorb glucose from the blood for energy. In insulin resistance, cells stop responding normally to insulin, causing the pancreas to produce more of it. High insulin directly stimulates the ovaries to produce more androgens, making insulin resistance a central driver of PCOS in most women.

A condition where the body's cells become less responsive to insulin, causing the pancreas to produce more of it to maintain normal blood sugar. In PCOS, high insulin directly stimulates the ovaries to overproduce androgens, disrupts ovulation, lowers SHBG, and promotes fat storage. Addressing insulin resistance is often the single most impactful intervention in PCOS management.

An integrative medicine doctor is a fully qualified medical doctor (typically a GP or specialist) who has undertaken additional training in integrative or functional medicine approaches. They combine evidence-based conventional medicine with complementary and lifestyle-based interventions including nutrition, herbal medicine, mind-body practices, targeted supplementation, and advanced diagnostic testing. The integrative approach is particularly well suited to PCOS because the condition has roots in multiple systems simultaneously and benefits from a comprehensive approach that addresses insulin resistance, inflammation, gut health, adrenal function, nutrient deficiencies, and psychological wellbeing alongside any pharmaceutical management. An integrative doctor will typically spend significantly more time with patients and order more comprehensive panels than a standard GP, and will be familiar with the kind of testing Dr Cooper recommends.

IVF is an assisted reproductive technology (ART) in which eggs are retrieved from the ovaries, fertilised with sperm in a laboratory, and the resulting embryo or embryos are transferred into the uterus. For women with PCOS, IVF is typically considered after first and second-line ovulation induction has not resulted in pregnancy. An important consideration specific to PCOS is the elevated risk of ovarian hyperstimulation syndrome (OHSS), a potentially serious complication caused by an exaggerated response to the hormonal stimulation used in IVF. Because women with PCOS have more follicles than average (reflected in high AMH), they are significantly more prone to OHSS. Careful protocol selection, lower stimulation doses, and the use of GnRH antagonist protocols with progesterone triggers rather than hCG substantially reduce this risk. Freezing all embryos for a subsequent frozen transfer cycle is often the safest approach for women with PCOS undergoing IVF.

The kidneys are two bean-shaped organs located at the back of the abdominal cavity whose primary function is filtering the blood and producing urine to excrete waste products and regulate fluid and electrolyte balance. In the context of endocrine and reproductive health, the kidneys are relevant for several reasons. They activate Vitamin D, converting the storage form (25-OH Vitamin D measured in blood tests) into its hormonally active form (1,25-dihydroxyvitamin D), meaning kidney health directly affects Vitamin D sufficiency and its downstream effects on insulin sensitivity and immune function. The kidneys also produce erythropoietin (which stimulates red blood cell production) and renin (which regulates blood pressure through the renin-angiotensin-aldosterone system). The adrenal glands sit directly above the kidneys, and the close anatomical relationship reflects their functional interconnection in regulating stress hormones, electrolytes, and blood pressure, all of which are relevant in PCOS with adrenal involvement.

A slowly progressing form of autoimmune diabetes that is often initially misdiagnosed as type 2 diabetes because it develops gradually in adults and may initially respond to lifestyle interventions. Like type 1 diabetes, LADA involves immune destruction of insulin-producing beta cells in the pancreas, detectable through GAD antibodies in the blood. In women presenting with PCOS and insulin resistance, LADA is an important condition to exclude, particularly if there is a personal or family history of autoimmune disease. This is one reason Dr Cooper includes GAD antibodies and anti-insulin antibodies in his comprehensive PCOS panel. Treating LADA as though it were standard insulin resistance without addressing the autoimmune component leads to progressively worsening glucose control.

A minimally invasive surgical procedure performed under general anaesthesia in which a small camera (laparoscope) is inserted through a tiny incision near the navel, allowing the surgeon to visualise the pelvic organs directly. In the context of PCOS and related conditions, laparoscopy is the gold standard diagnostic procedure for endometriosis, as it is the only way to definitively confirm endometrial lesions outside the uterus. It is also used to investigate unexplained pelvic pain, assess tubal patency (whether the fallopian tubes are open), and perform ovarian drilling (LOD) for PCOS when ovulation induction medications have not worked. Laparoscopic ovarian drilling involves making small punctures in the ovary to reduce androgen-producing tissue and lower LH, which can restore ovulation in some women with medication-resistant PCOS.

Often called bad cholesterol, LDL carries cholesterol to the arteries where it can accumulate and contribute to cardiovascular disease. Elevated LDL is more common in women with PCOS, particularly those with insulin resistance and central adiposity.

Intestinal permeability, commonly called leaky gut, refers to a breakdown in the tight junction proteins that normally control what passes through the intestinal wall into the bloodstream. When these junctions are compromised, partially digested food particles, bacterial toxins (particularly lipopolysaccharide or LPS), and other compounds can enter the bloodstream, triggering a chronic systemic immune response and inflammation. In PCOS, increased intestinal permeability has been demonstrated in research and is considered one of the drivers of the chronic low-grade inflammation that worsens insulin resistance, disrupts hormone metabolism, and perpetuates androgen excess. Factors that increase intestinal permeability include a low-fibre diet, processed foods, chronic stress, alcohol, non-steroidal anti-inflammatory medications (NSAIDs), and dysbiosis. Supporting gut integrity through dietary fibre, fermented foods, glutamine, zinc, and reducing inflammatory triggers is increasingly recognised as a meaningful part of PCOS management.

Lean PCOS refers to PCOS in women who have a body mass index (BMI) in the normal range, typically below 25. It is one of the most misunderstood and underdiagnosed presentations of PCOS, because both popular culture and many medical practitioners associate the condition almost exclusively with weight gain. Approximately 20 to 30% of women with PCOS are lean, and many spend years being dismissed by doctors who tell them they cannot have PCOS because they are not overweight. Lean PCOS tends to present with a stronger hormonal and androgenic picture, often with more pronounced LH excess relative to FSH, higher androgen levels, and more significant menstrual irregularity despite the absence of metabolic features like obesity or severe insulin resistance. While insulin resistance is still often present in lean PCOS, it manifests differently and may not be captured by standard fasting glucose tests alone, making fasting insulin, HOMA-IR, and the glucose tolerance test essential. The absence of visible metabolic features does not mean the condition is less serious. Lean women with PCOS carry the same long-term reproductive and hormonal risks and deserve the same thorough investigation and support.

A hormone produced by fat cells that signals satiety to the brain and plays a role in regulating the menstrual cycle. Women with PCOS often have leptin resistance, meaning the brain does not respond normally to leptin signals, contributing to persistent hunger, weight gain, and disrupted ovulation.

Produced by the pituitary gland, LH triggers ovulation when it surges mid-cycle. In PCOS, the LH to FSH ratio is often elevated (2:1 or higher), which suppresses ovulation and drives androgen production in the ovaries.

The liver is the body's primary metabolic and detoxification organ, performing over 500 distinct functions that are central to hormonal health. In the context of PCOS, its most important roles include producing SHBG (which binds and regulates free sex hormones), performing Phase 1 and Phase 2 detoxification of used oestrogens and androgens, synthesising cholesterol as the raw material for all steroid hormones, metabolising insulin and clearing excess glucose, processing and storing fat, and producing IGF-1 in response to growth hormone. When the liver is overburdened by insulin resistance, excess androgens, environmental toxins, a poor diet, or alcohol, its hormone-clearing capacity diminishes, contributing to oestrogen dominance, elevated androgens, and worsening metabolic dysfunction. Non-alcoholic fatty liver disease (NAFLD), which is significantly more prevalent in women with PCOS, directly impairs all of these functions. Supporting liver health through cruciferous vegetables, adequate dietary fibre, Calcium D-Glucarate, NAC, and reducing processed food and alcohol intake is a foundational aspect of hormonal balance in PCOS.

The lymphatic system is a network of vessels, nodes, and organs that runs parallel to the circulatory system and serves as the body's drainage and immune surveillance network. It collects excess fluid from tissues, filters it through lymph nodes where immune cells screen for pathogens and abnormal cells, and returns it to the bloodstream. In the context of hormonal and reproductive health, the lymphatic system plays an important but often overlooked role in clearing metabolic waste, inflammatory mediators, and immune complexes from tissues including the pelvic organs. Poor lymphatic drainage contributes to chronic pelvic congestion, bloating, and inflammation. In women with endometriosis and PCOS, impaired lymphatic flow in the pelvis may contribute to the accumulation of inflammatory signals. Practices that support lymphatic circulation include regular movement, deep breathing, hydration, dry body brushing, and manual lymphatic drainage massage.

One of the most important minerals in PCOS management, involved in over 300 enzymatic reactions including insulin signalling, glucose metabolism, cortisol regulation, sleep, muscle relaxation, and nerve function. Magnesium deficiency is extremely common in women with PCOS and in the general population due to soil depletion and low dietary intake. However, the form of magnesium determines where and how it works in the body, and choosing the wrong form means most of it is lost in the stool. Magnesium glycinate (bound to glycine) is the best-absorbed form for general supplementation, supports sleep, anxiety, and muscle tension, and is gentle on the gut. Magnesium malate (bound to malic acid) supports energy production and is preferred for fatigue and fibromyalgia. Magnesium threonate (bound to threonic acid) crosses the blood-brain barrier and is the only form that meaningfully raises magnesium levels in the brain, making it the preferred choice for cognitive function, mood, and neurological support. Magnesium citrate is moderately bioavailable and has a mild laxative effect, making it useful for constipation. Magnesium oxide, the cheapest and most common form in supplements, has less than 4% bioavailability and is largely ineffective for correcting deficiency. Genetic variants in magnesium transporter genes, particularly TRPM6 and TRPM7, can significantly impair magnesium absorption from the gut regardless of dietary or supplemental intake, meaning some women require higher doses or intravenous repletion to correct deficiency.

A byproduct of lipid peroxidation, measured in urine as a marker of oxidative stress. Elevated MDA indicates that free radicals are damaging cell membranes. Women with PCOS have measurably higher MDA levels than healthy controls, contributing to impaired egg quality, inflammation, and metabolic dysfunction. This is part of Dr Cooper's pro-oxidant assessment panel.

Best known as the sleep hormone, melatonin is also present in ovarian follicular fluid and plays a role in egg quality and ovulation. Research suggests women with PCOS have altered melatonin rhythms, which may contribute to sleep disturbances and menstrual irregularity. Consistent sleep timing helps support healthy melatonin production.

Defined as the point 12 consecutive months after a woman's last menstrual period, marking the end of reproductive capacity. The average age of natural menopause is 51, though it ranges from 45 to 55. Menopause is confirmed retrospectively and the years leading up to it are perimenopause. After menopause, oestrogen production by the ovaries drops dramatically, progesterone falls to near zero, and testosterone also declines, though more gradually. The post-menopausal hormonal environment significantly increases the risk of osteoporosis, cardiovascular disease, cognitive decline, and metabolic dysfunction. For women with a history of PCOS, the transition into menopause requires particular vigilance because the insulin resistance and chronic inflammation that drove their PCOS do not simply resolve with the cessation of periods. They may in fact worsen as the protective metabolic effects of oestrogen are lost. On the other hand, many of the most distressing androgenic symptoms of PCOS, including hirsutism and acne, often improve post-menopause as androgens gradually decline. Herbs commonly used to support menopausal symptoms include black cohosh, dong quai, and wild yam, all of which have oestrogenic activity and should be approached with an understanding of an individual woman's full hormonal picture before use.

A healthy menstrual cycle is not just about bleeding. It is a carefully orchestrated sequence of four distinct phases, each governed by different hormones and each affecting energy, mood, metabolism, skin, libido, and cognition in measurable ways. Understanding your cycle phases is one of the most powerful tools available for managing PCOS. Phase 1 is Menstruation (days 1 to 5 on average), when the uterine lining sheds as progesterone and oestrogen both fall. Energy is naturally lower and inward rest is appropriate. Iron, magnesium, and anti-inflammatory foods are particularly supportive during this phase. Phase 2 is the Follicular Phase (days 1 to 13, overlapping with menstruation), when FSH rises and stimulates follicle development in the ovaries. Oestrogen begins to climb, bringing rising energy, clearer thinking, improved mood, and greater motivation. In PCOS this phase is often prolonged because follicles struggle to reach full maturity. Phase 3 is Ovulation (around day 14 in a textbook 28-day cycle), when the LH surge triggers the release of a mature egg. Oestrogen peaks just before ovulation, producing the highest energy, confidence, and libido of the cycle. In PCOS, ovulation is infrequent or absent, which means many women skip this phase entirely for months at a time. Confirming ovulation through basal body temperature tracking or LH test strips is valuable for understanding your individual pattern. Phase 4 is the Luteal Phase (days 15 to 28), when the corpus luteum produces progesterone to prepare the uterine lining for potential implantation. Progesterone has a calming, warming, and slightly sedating effect. If there is no pregnancy, progesterone drops sharply at the end of this phase, triggering menstruation. In PCOS, a short or absent luteal phase due to poor ovulation quality means progesterone is low, which drives PMS, PMDD, mood instability, poor sleep, and heavy or irregular bleeding. Supporting ovulation through the entire cycle is the most effective way to restore a healthy luteal phase and the progesterone that comes with it.

A cluster of five metabolic abnormalities that together significantly increase the risk of type 2 diabetes and cardiovascular disease. The five components are elevated waist circumference (central obesity), elevated triglycerides, low HDL cholesterol, elevated blood pressure, and elevated fasting glucose. Having 3 or more of these criteria meets the definition of metabolic syndrome. Women with PCOS have a 2 to 3 times higher risk of metabolic syndrome compared to women without PCOS, driven primarily by insulin resistance, chronic inflammation, and androgen excess. Addressing metabolic syndrome in PCOS requires a comprehensive approach targeting insulin sensitivity, inflammation, lipid balance, and body composition simultaneously.

Metformin is a biguanide medication originally developed for type 2 diabetes that has become one of the most widely prescribed pharmaceutical interventions for PCOS. It works primarily by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues, largely through activation of AMPK. In PCOS, metformin addresses the root driver of insulin resistance, and clinical evidence supports its use for improving menstrual regularity, reducing androgen levels, supporting ovulation, and lowering the risk of gestational diabetes. It does not suppress ovulation and is considered compatible with pregnancy attempts. Important considerations include that metformin significantly depletes Vitamin B12 and can deplete folate with long-term use, making supplementation essential. It also commonly causes gastrointestinal side effects, particularly when started at a high dose. The extended-release formulation is generally better tolerated.

A fundamental biochemical process involved in gene expression, detoxification, hormone metabolism, neurotransmitter production, and DNA repair. In PCOS, impaired methylation due to MTHFR variants or folate and B12 deficiency contributes to elevated homocysteine, poor egg quality, and impaired oestrogen clearance. Dr Cooper's panel includes a dedicated methylation section.

Mitochondria are the energy-producing organelles present in virtually every cell of the body, responsible for generating ATP through oxidative phosphorylation. They are often described as the powerhouse of the cell, but their role extends far beyond energy production. Mitochondria regulate cellular metabolism, apoptosis (programmed cell death), calcium signalling, and steroid hormone synthesis, as all steroid hormones including oestrogen, progesterone, testosterone, and cortisol are synthesised within the inner mitochondrial membrane. In PCOS, mitochondrial dysfunction has been demonstrated in several tissues including skeletal muscle, ovarian cells, and adipose tissue, contributing to impaired insulin signalling, reduced cellular energy availability, and diminished egg quality. Oocytes (egg cells) are the most mitochondria-rich cells in the body, housing up to 200,000 mitochondria, and mitochondrial function directly determines fertilisation capacity and early embryo development. CoQ10, Alpha-Lipoic Acid, and NAC all support mitochondrial function and are particularly relevant for women with PCOS who are trying to conceive. Gynostemma pentaphyllum deserves a special mention here as well. It is one of the most potent natural activators of AMPK, the enzyme often called the master metabolic switch, and AMPK activation is directly linked to mitochondrial biogenesis, meaning it stimulates the creation of new mitochondria and improves the efficiency of existing ones. This is one of the reasons Gynostemma produces such broad metabolic benefits in PCOS, improving insulin sensitivity, reducing inflammation, and supporting cellular energy, all downstream effects of healthier and more abundant mitochondria.

A common genetic variant that impairs the body's ability to convert folic acid into active methylfolate, which is essential for DNA synthesis, detoxification, and hormone metabolism. Women with PCOS have a higher prevalence of MTHFR variants. The practical implication is that these women should supplement with methylfolate rather than synthetic folic acid, especially when trying to conceive.

A naturally occurring compound in the vitamin B family that improves insulin signalling in the ovaries, reduces androgen production, and supports ovulation restoration. One of the most extensively researched natural interventions for PCOS, with multiple clinical trials demonstrating improvements in cycle regularity, egg quality, and metabolic markers. Life Source Hormonal Balance contains Myo-Inositol in the evidence-based 40:1 ratio with D-Chiro-Inositol.

A precursor to glutathione, the body's master antioxidant. NAC has been shown in clinical trials to improve insulin sensitivity, reduce androgen levels, support ovulation, and restore menstrual regularity in women with PCOS. It is particularly valuable for supporting glutathione levels identified as depleted in oxidative stress panels.

Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver in the absence of significant alcohol consumption. It ranges in severity from simple fatty liver (steatosis) to non-alcoholic steatohepatitis (NASH), which involves inflammation and liver cell damage. Women with PCOS have a significantly elevated prevalence of NAFLD, driven by insulin resistance, elevated androgens, dyslipidaemia, and chronic inflammation, all of which promote hepatic fat accumulation. The liver is also central to hormone metabolism and oestrogen clearance, meaning that compromised liver function worsens hormonal imbalance in PCOS. NAFLD is often silent until advanced, making it important to screen for in women with PCOS who have insulin resistance and dyslipidaemia. Liver function tests (ALT, AST, GGT) and a liver ultrasound are the standard screening tools.

The title nutritionist is not legally protected in South Africa or in many other countries, which means anyone can technically call themselves a nutritionist regardless of their training or qualifications. In practice, nutritionists range from individuals with no formal training to those with undergraduate or postgraduate degrees in nutritional science. A registered nutritional therapist or clinical nutritionist with a recognised qualification and professional registration can provide genuinely valuable evidence-based guidance, particularly for the dietary, lifestyle, and supplementation aspects of PCOS management. When seeking support, it is important to ask specifically about qualifications, professional registration, and clinical experience with hormonal and metabolic conditions.

An OB-GYN is a medical doctor who has completed dual specialist training in both obstetrics (the care of women during pregnancy, labour, and the postpartum period) and gynaecology (the health of the female reproductive system outside of pregnancy). This makes them uniquely positioned to support women across the full reproductive lifespan, from menstrual health and contraception through fertility, pregnancy, birth, and beyond. For women with PCOS, an OB-GYN is particularly relevant when pregnancy is being planned or has occurred, as PCOS carries specific pregnancy-related risks including gestational diabetes, preeclampsia, and preterm birth that require specialist monitoring. Many OB-GYNs also manage PCOS in the non-pregnant context, though the depth of metabolic and endocrine expertise varies between practitioners. In South Africa, obstetricians and gynaecologists are registered with the HPCSA and the South African Society of Obstetricians and Gynaecologists (SASOG). For complex PCOS with fertility challenges, a referral to a reproductive endocrinologist within an OB-GYN practice or a dedicated fertility clinic is often the most comprehensive pathway.

The most potent and predominant form of oestrogen, produced primarily by the ovarian follicles. Oestradiol levels fluctuate throughout the cycle and are used to assess follicular development and ovarian function. In PCOS, oestradiol may be normal or slightly elevated depending on the phase and degree of follicular activity.

The primary female sex hormone, produced mainly by the ovaries. Oestrogen regulates the menstrual cycle, supports bone density, cardiovascular health, skin moisture, and mood. In PCOS, oestrogen is often not deficient but becomes unopposed when progesterone is low due to absent ovulation, which can thicken the uterine lining over time.

A hormonal state in which oestrogen is elevated relative to progesterone, creating an imbalance that drives a cluster of symptoms and conditions. It does not necessarily mean oestrogen is above the normal range in absolute terms. What matters is the ratio. When progesterone is low (as it commonly is in PCOS due to infrequent ovulation), oestrogen goes relatively unopposed, even at normal levels. Symptoms of oestrogen dominance include heavy or irregular periods, breast tenderness, bloating, mood swings, fatigue, weight gain around the hips and thighs, worsening PMS, and heightened anxiety. Oestrogen dominance is the underlying hormonal pattern in endometriosis, adenomyosis, PMDD, uterine fibroids, and many cases of PCOS. Supporting oestrogen clearance through the liver and gut (Calcium D-Glucarate, cruciferous vegetables, adequate fibre), supporting progesterone production through ovulation restoration, and avoiding oestrogenic herbs and excess dietary phytoestrogens are all key strategies.

Menstrual cycles longer than 35 days, resulting in fewer than 9 periods per year. It is one of the cardinal signs of PCOS and reflects infrequent or absent ovulation. Some women with oligomenorrhoea have periods that feel heavier than normal when they do arrive, because the endometrial lining has had longer to build up.

Omega-3 fatty acids, particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) found in fatty fish and fish oil, are among the most extensively researched anti-inflammatory nutrients relevant to PCOS. They reduce prostaglandin-driven inflammation, lower triglycerides, improve insulin sensitivity, support healthy cell membrane function, and have been shown in clinical trials to reduce testosterone and improve menstrual regularity in women with PCOS. DHA is also critical for brain development, making omega-3 supplementation particularly important for women with PCOS who are pregnant or trying to conceive. The ratio of omega-6 to omega-3 in the modern diet is typically around 20:1, far above the 4:1 or lower ratio associated with reduced inflammation. Plant-based ALA (found in flaxseed and chia) has limited conversion to EPA and DHA and is not an equivalent substitute. For therapeutic benefit in PCOS, a combined EPA and DHA supplement from fish or algae sources is the most reliable approach.

A fluid-filled sac on or inside the ovary. The small follicles seen in PCOS are often referred to as cysts but are technically follicles that failed to mature, not true cysts. Functional cysts can form when a follicle grows but does not release an egg, or when the corpus luteum fills with fluid. Most functional cysts resolve on their own within a few months.

An imbalance between free radicals and antioxidants in the body, leading to cellular damage. Women with PCOS have measurably higher levels of oxidative stress, which impairs egg quality, worsens inflammation, and disrupts insulin signalling. Antioxidant-rich foods and supplements including Vitamin C, Vitamin E, Alpha-Lipoic Acid, and NAC help counter oxidative stress in PCOS.

A protein involved in blood clot breakdown. Elevated PAI-1 reduces the body's ability to dissolve clots and is associated with a higher risk of thrombosis and miscarriage. PAI-1 levels are elevated in insulin-resistant states including PCOS, making it part of Dr Cooper's thrombosis panel for comprehensive cardiovascular risk assessment.

The pancreas is a glandular organ situated behind the stomach with two distinct functions. Its exocrine function produces digestive enzymes released into the small intestine to break down food. Its endocrine function produces hormones released directly into the bloodstream, most critically insulin and glucagon from clusters of cells called the islets of Langerhans. Beta cells produce insulin in response to rising blood glucose, while alpha cells produce glucagon to raise blood glucose when it falls too low. In PCOS, the pancreatic beta cells are under chronic pressure because insulin resistance requires them to produce far more insulin than normal to achieve the same blood glucose lowering effect. Over years of this elevated demand, beta cell function can begin to decline, increasing the risk of type 2 diabetes. Supporting insulin sensitivity through diet, exercise, and targeted supplementation directly reduces the burden on the pancreas and protects long-term beta cell health.

Parathyroid hormone is produced by the four small parathyroid glands located behind the thyroid gland and is the primary regulator of calcium and phosphate balance in the blood. When blood calcium falls, PTH rises to restore it by stimulating calcium release from bone, increasing calcium reabsorption in the kidneys, and activating Vitamin D in the kidneys to enhance calcium absorption from the gut. In the context of female hormonal health, PTH is most relevant through its relationship with Vitamin D and calcium metabolism. Vitamin D deficiency, which is extremely common in women with PCOS, causes secondary hyperparathyroidism, meaning PTH rises chronically to compensate for poor calcium absorption. Chronically elevated PTH draws calcium from bone, increasing osteoporosis risk. It also has metabolic effects including impairing insulin secretion from pancreatic beta cells, providing a direct mechanistic link between Vitamin D deficiency and worsened insulin resistance in PCOS. In perimenopause and menopause, the loss of oestrogen accelerates bone resorption and dysregulates the PTH-Vitamin D-calcium axis significantly, making bone health monitoring and Vitamin D optimisation critical during this transition.

The psychological burden of PCOS is profound and consistently underacknowledged in clinical settings. Research shows that women with PCOS have significantly elevated rates of anxiety, depression, disordered eating, body dysmorphia, and reduced quality of life compared to women without the condition. The causes are both biological and psychosocial. Biologically, androgen excess, insulin resistance, chronic inflammation, progesterone deficiency, and disrupted sleep all directly affect neurotransmitter systems including serotonin, dopamine, and GABA, creating a neurochemical environment that predisposes toward anxiety and low mood. Psychosocially, the visible symptoms of PCOS including acne, unwanted hair, scalp hair loss, and weight changes significantly affect self-esteem, body image, and social confidence. The experience of irregular or absent periods, fertility uncertainty, and feeling dismissed by the medical system adds further psychological weight. Mental health support is not a secondary concern in PCOS management. It is a central one. Addressing the biological drivers through nutrition, supplementation, and lifestyle creates measurable improvements in mood and anxiety, and psychological support through therapy, community connection, and compassionate care is equally important.

Diagnosing and managing PCOS in teenagers requires a different and more careful approach than in adult women. Irregular cycles, acne, and polycystic ovarian morphology on ultrasound are all normal features of the first 1 to 2 years after a first period as the hormonal axis matures, which means the standard Rotterdam diagnostic criteria cannot be applied in the same way to adolescents. International guidelines recommend that a definitive PCOS diagnosis in a teenager should not be made until at least 2 years after the first period, and should require both hyperandrogenism and menstrual irregularity without relying on ultrasound alone. Unfortunately, many teenage girls are diagnosed quickly and placed immediately on the combined oral contraceptive pill without any investigation of the metabolic, nutritional, or lifestyle factors involved. The pill suppresses the very hormonal development the teenage ovaries are attempting to establish and does not treat the underlying condition at all. Early metabolic and nutritional intervention, lifestyle support, and a watchful approach to diagnosis are far more appropriate first-line responses in adolescents. This age group also carries a particularly high psychological burden from visible androgenic symptoms during an already vulnerable developmental period, making compassionate, thorough care especially important.

One of the most underrecognised and under-discussed realities of PCOS is that it does not end at menopause. PCOS is a lifelong metabolic and endocrine condition, and many of its most significant health implications actually emerge in the post-menopausal years. The insulin resistance that drives PCOS in the reproductive years persists after menopause and is often amplified by the loss of oestrogen's protective metabolic effects. This significantly elevates the long-term risk of type 2 diabetes, cardiovascular disease, non-alcoholic fatty liver disease, and cognitive decline in women with a history of PCOS. Interestingly, the hormonal landscape of menopause can also blur the clinical picture. As ovarian androgen production gradually declines with age, some of the more visible androgenic symptoms of PCOS such as hirsutism and acne may soften or resolve, which can lead women and even their doctors to assume the condition has resolved. It has not. The metabolic underpinnings remain. What also changes is that the traditional diagnostic markers used to identify PCOS in younger women, including elevated LH, polycystic ovarian morphology on ultrasound, and irregular cycles, are no longer applicable after menopause. This means PCOS in post-menopausal women is often invisible in the medical system. Women who know their history and continue to support their metabolic health through diet, movement, targeted supplementation, stress management, and regular metabolic monitoring are in the strongest position to age well with PCOS.

The transitional phase leading up to menopause, typically beginning in a woman's early to mid-40s, though it can start as early as the mid-30s in some women. Perimenopause is characterised by fluctuating and increasingly erratic oestrogen levels, declining progesterone, shortening or lengthening cycles, heavier or lighter periods, and the gradual onset of symptoms including hot flushes, night sweats, sleep disturbances, mood changes, brain fog, vaginal dryness, joint pain, and changes in libido. It is not a single hormonal event but a transition that can last anywhere from 2 to 12 years. For women with PCOS, perimenopause can be particularly complex. The insulin resistance and androgen excess that characterised their reproductive years often persist or worsen during this transition. Interestingly, some women with PCOS find their cycles become more regular in perimenopause as LH and FSH begin to rise naturally, but the broader metabolic picture requires ongoing attention. Progesterone declines first and most steeply in perimenopause, often years before oestrogen drops significantly, which means oestrogen dominance frequently worsens before it improves. This is the phase where magnesium, Vitex, adaptogenic support, and anti-inflammatory lifestyle interventions become especially valuable.

Phytoestrogens are naturally occurring plant compounds that can bind to oestrogen receptors in the human body and produce weak oestrogen-like effects. They are found in soy and soy-based products (isoflavones), flaxseeds (lignans), red clover, chickpeas, lentils, sesame seeds, and many herbal supplements. The word phytoestrogen sounds alarming to many women, but the reality is nuanced. These compounds are far weaker than the body's own oestrogen and in some contexts can actually have an anti-oestrogenic effect by occupying receptors without fully activating them, blocking stronger oestrogens from binding. However, in women who are already oestrogen dominant, including many women with PCOS, endometriosis, PMDD, adenomyosis, and uterine fibroids, a high dietary phytoestrogen load can tip the hormonal balance further toward oestrogen excess and worsen symptoms. The safest approach for women with these conditions is to be aware of concentrated phytoestrogen sources, such as soy protein isolates and high-dose red clover supplements, while whole food sources in moderate amounts are generally less concerning. If in doubt, testing your oestrogen levels and working with a knowledgeable practitioner is the most informed path forward.

A small pea-shaped gland located deep in the centre of the brain, the pineal gland is the primary producer of melatonin, the hormone that regulates the body's circadian rhythm and sleep-wake cycle. The pineal gland receives light signals from the retina and suppresses melatonin production during daylight, releasing it in rising quantities after darkness to promote sleep. In the context of PCOS, the pineal gland is relevant for several reasons. Melatonin is not only a sleep hormone but is present in high concentrations in ovarian follicular fluid, where it acts as a powerful antioxidant protecting developing eggs from oxidative damage. Research has found altered melatonin secretion patterns in women with PCOS, which may contribute to the sleep disturbances, disrupted circadian rhythms, and impaired egg quality seen in the condition. Artificial light exposure after dark, including screens and indoor lighting, suppresses pineal melatonin production, directly impairing both sleep quality and reproductive antioxidant protection.

A small gland at the base of the brain that produces FSH and LH in response to signals from the hypothalamus. In PCOS, disrupted signalling causes the pituitary to favour LH production over FSH, which drives androgen production and prevents normal follicle maturation.

The placenta is a temporary organ that develops during pregnancy, attaching to the uterine wall and connecting to the developing fetus through the umbilical cord. It serves as the interface between mother and baby, facilitating the transfer of oxygen, nutrients, antibodies, and hormones to the fetus while removing waste products. The placenta is also a powerful endocrine organ in its own right, producing human chorionic gonadotropin (hCG), progesterone, oestrogen, human placental lactogen (hPL), and other hormones that sustain pregnancy and prepare the maternal body for birth and breastfeeding. In women with PCOS, placental function is an area of active research. The insulin resistance and chronic inflammation of PCOS affect placental development and function, contributing to the elevated risks of gestational diabetes, preeclampsia, and preterm birth seen in PCOS pregnancies. Understanding the placenta as a hormone-producing organ, not merely a nutritional conduit, helps explain why maternal hormonal and metabolic health before and during pregnancy has such profound effects on pregnancy outcomes.

A severe form of premenstrual syndrome (PMS) characterised by debilitating mood changes in the 1 to 2 weeks before menstruation, including severe depression, anxiety, irritability, rage, and emotional dysregulation that significantly impairs daily functioning and relationships. PMDD is distinct from ordinary PMS in its severity and its profound impact on mental health and quality of life. It is driven by an abnormal sensitivity of the brain to the natural hormonal fluctuations of the luteal phase, particularly the drop in progesterone and changes in serotonin and GABA signalling. Women with PCOS have higher rates of PMDD, likely because progesterone deficiency from irregular ovulation amplifies this sensitivity. PMDD is also an oestrogen-sensitive condition, meaning high oestrogen relative to progesterone worsens symptoms. Management approaches include cycle-tracking, progesterone support, magnesium glycinate, Vitex, B6, and in some cases antidepressants targeting serotonin pathways in the luteal phase only.

The appearance of many small follicles on a transvaginal ultrasound, typically defined as 20 or more follicles per ovary or an ovarian volume greater than 10ml. Despite the name, these are follicles rather than true cysts. Polycystic ovarian morphology is one of the Rotterdam diagnostic criteria for PCOS but can also appear in women who do not have the condition.

A term used to describe the cluster of symptoms that can emerge after stopping hormonal contraception, particularly the combined oral contraceptive pill. Because the pill suppresses the HPO axis for the duration of its use, the hypothalamus, pituitary, and ovaries need time to re-establish their natural communication and rhythm after the pill is stopped. This recovery period varies enormously between women, from a few weeks to over a year. Common symptoms include delayed return of periods (post-pill amenorrhoea), worsening acne (often more severe than before starting the pill), hair loss, mood changes, anxiety, and the re-emergence of PCOS symptoms in full. For women with PCOS, stopping the pill can feel like their condition has dramatically worsened, when in reality the pill was always only masking symptoms rather than treating their root cause. Supporting the HPO axis recovery with nutritional repletion (particularly B vitamins, zinc, and magnesium depleted by the pill), liver support, seed cycling, and targeted supplements including Myo-Inositol and Vitex is a well-reasoned approach during this transition.

Preeclampsia is a serious pregnancy complication characterised by high blood pressure and signs of organ damage, most commonly affecting the kidneys, developing after 20 weeks of pregnancy. It affects approximately 2 to 8% of pregnancies globally and is a leading cause of maternal and perinatal morbidity and mortality. Women with PCOS have a significantly elevated risk of preeclampsia, with studies suggesting roughly double the risk compared to women without PCOS. The shared mechanisms include chronic inflammation, endothelial dysfunction, insulin resistance, and oxidative stress, all of which are elevated in PCOS and contribute to the vascular dysfunction underlying preeclampsia. Symptoms include persistent headache, visual disturbances, upper abdominal pain, sudden swelling, and reduced fetal movement. Any of these symptoms in pregnancy require immediate medical assessment.

Premature ovarian insufficiency (POI), previously called premature menopause, is the loss of normal ovarian function before the age of 40, characterised by irregular or absent periods, elevated FSH, low oestrogen, and often subfertility. It is distinct from PCOS. Where PCOS involves ovaries that have many follicles but are not releasing them properly, POI involves a depletion or dysfunction of the follicular pool itself. The two conditions can be confused because both involve menstrual irregularity and elevated FSH, but the distinction is important because management is very different. POI requires oestrogen replacement to protect bone density and cardiovascular health, whereas PCOS typically does not. AMH is usually very low in POI and elevated in PCOS, making it a useful distinguishing marker.

Preterm birth is defined as delivery before 37 completed weeks of pregnancy. It is a leading cause of neonatal morbidity and mortality worldwide. Women with PCOS have an elevated risk of preterm birth, with research suggesting approximately 1.5 to 2 times the risk compared to women without PCOS. The contributing factors include higher rates of multiple pregnancy from assisted reproduction, greater prevalence of gestational diabetes and hypertensive disorders in PCOS pregnancies, and the chronic inflammatory state that characterises PCOS. Preterm infants face risks including respiratory distress, feeding difficulties, temperature regulation challenges, and longer-term developmental concerns. Optimising maternal health before and during pregnancy through managing insulin resistance, inflammation, and nutrient status reduces overall pregnancy complication risk in women with PCOS.

Measured in the second half of the cycle (day 21 of a 28-day cycle) to confirm whether ovulation has occurred. A low day-21 progesterone confirms anovulation. In women with PCOS and irregular cycles, timing this test can be challenging, but it remains one of the most direct ways to assess ovulatory function.

Produced after ovulation by the corpus luteum, progesterone is one of the most important and frequently deficient hormones in women with PCOS. It counterbalances oestrogen, supports the uterine lining, promotes sleep, reduces anxiety, supports thyroid function, and has anti-inflammatory properties. In the brain, progesterone converts to allopregnanolone, a neurosteroid that activates GABA receptors and produces a calming effect. Without ovulation there is no corpus luteum and no progesterone, which is why anovulation in PCOS leads not only to irregular periods but also to poor sleep, anxiety, mood instability, worsening PMS, and endometrial thickening. Natural progesterone (bioidentical) produces all of these beneficial effects. Synthetic progestins found in contraceptives do not replicate them and some actively oppose them.

A hormone that regulates milk production but is also measured in PCOS workups because elevated prolactin can mimic PCOS symptoms including irregular cycles. If your prolactin is high, your doctor will want to rule out a benign pituitary tumour called a prolactinoma before confirming a PCOS diagnosis.

A second common inherited clotting disorder that increases prothrombin levels and raises the risk of venous thromboembolism. Like Factor V Leiden, it is screened in women with PCOS as part of a comprehensive cardiovascular and thrombosis risk assessment, particularly relevant before prescribing hormonal treatments or planning pregnancy.

Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses before 20 weeks of gestation. Women with PCOS have an elevated risk of miscarriage compared to women without PCOS, with some studies suggesting up to twice the risk. The contributing factors include insulin resistance (which impairs endometrial receptivity and early placentation), elevated LH (which can impair egg quality and fertilisation), elevated androgens, progesterone deficiency from poor corpus luteum function, and chronic inflammation. The presence of inherited thrombophilias including Factor V Leiden and the prothrombin gene mutation, which Dr Cooper screens for routinely, also significantly increases miscarriage risk through impaired placental blood flow. Optimising insulin resistance, supporting progesterone levels in the luteal phase, correcting nutrient deficiencies, and screening for thrombophilias are all important steps in evaluating and supporting women with PCOS who have experienced recurrent loss.

Measures folate stored within red blood cells, reflecting long-term folate status over the past 2 to 3 months, unlike serum folate which reflects only recent intake. Low red cell folate impairs DNA synthesis, egg quality, and methylation. It is measured as part of Dr Cooper's methylation panel alongside MTHFR and homocysteine.

The internationally accepted framework for diagnosing PCOS, requiring 2 of the following 3 features: irregular or absent ovulation, clinical or biochemical evidence of hyperandrogenism, and polycystic ovarian morphology on ultrasound. Other causes of these findings must be excluded first. Because diagnosis requires only 2 of 3 criteria, PCOS presents differently in different women.

Occurs when an ovarian cyst breaks open, releasing its fluid into the pelvic cavity. This can cause sudden, sharp pelvic pain, sometimes with nausea or light-headedness. Most ruptured cysts resolve without treatment and the fluid is reabsorbed naturally. However, if the cyst was large or involved bleeding, medical attention is required to rule out internal haemorrhage.

Saw palmetto is a plant extract best known for its use in benign prostatic hyperplasia in men, but increasingly recognised for its anti-androgenic benefits in women with PCOS. Its primary mechanism is inhibition of 5-alpha reductase, the enzyme responsible for converting testosterone into the more potent DHT. By reducing DHT formation, saw palmetto can help manage androgenic symptoms including scalp hair thinning, hirsutism, and acne. It does not lower testosterone itself but limits its conversion to the more tissue-active form. It is generally well tolerated in women, though it should be avoided in pregnancy. For women experiencing pronounced DHT-driven symptoms alongside PCOS, saw palmetto is a well-reasoned addition to a comprehensive protocol alongside insulin-sensitising and anti-androgenic interventions.

A research scientist working in the fields of endocrinology, reproductive medicine, biochemistry, or nutritional science is the person behind the clinical evidence that informs PCOS treatment. Scientists design and conduct studies, publish findings in peer-reviewed journals, and build the evidence base that eventually makes its way into clinical practice, often years later. It is worth understanding that a scientist is not the same as a clinician. A researcher may have deep expertise in a specific molecule or mechanism but not in treating patients. Conversely, an experienced clinician may have profound practical wisdom that is not yet reflected in published research. The most robust PCOS care integrates both, drawing on published science while also respecting the clinical experience of practitioners who work with women directly every day. Dr Cooper's approach to PCOS testing is an example of clinical expertise that goes well beyond standard protocols.

Seed cycling is a food-based practice that involves eating specific seeds during each phase of the menstrual cycle with the intention of gently supporting the body's natural hormonal rhythm. During the follicular phase (day 1 to 14), flaxseeds and pumpkin seeds are consumed daily. Flaxseeds are rich in lignans, a type of phytoestrogen that may help modulate oestrogen activity, while pumpkin seeds are high in zinc which supports progesterone production in preparation for ovulation. During the luteal phase (day 15 to 28), sesame seeds and sunflower seeds are consumed. Sesame seeds contain lignans and selenium which support progesterone and liver detoxification, while sunflower seeds are rich in Vitamin E and selenium which support luteal phase health. The scientific evidence for seed cycling as a clinical intervention is limited and largely anecdotal, and it should not replace medical treatment for PCOS or other hormonal conditions. However, many women report improved cycle awareness, reduced PMS, and greater connection to their body through this practice, and the seeds themselves are genuinely nutritious. For women with oestrogen dominance, it is worth noting that flaxseeds and sesame seeds contain phytoestrogens, so introducing them gradually and observing how your body responds is a sensible approach.

Selenium is an essential trace mineral that serves as a cofactor for a family of antioxidant enzymes called selenoproteins, including glutathione peroxidase, which is central to reducing oxidative stress. It also plays a critical role in thyroid hormone metabolism, specifically in the conversion of the inactive T4 into the active T3 in peripheral tissues. Selenium deficiency impairs thyroid function, worsens oxidative stress, and reduces antioxidant capacity. In the context of PCOS and Hashimoto's thyroiditis, selenium supplementation has been shown to reduce thyroid antibody levels (anti-TPO), slow the progression of autoimmune thyroid damage, and improve thyroid hormone conversion. Brazil nuts are the richest dietary source, with a single nut providing approximately a full daily requirement, though consistency of content varies by soil. Supplemental selenium should be used at physiological doses (100 to 200mcg daily) as excess selenium is toxic.

A morning blood draw measuring cortisol at its natural daily peak, used to assess adrenal function. In PCOS, elevated cortisol from chronic stress drives adrenal androgen production, worsens insulin resistance, promotes central fat storage, and suppresses ovulation. Low cortisol can indicate adrenal fatigue or insufficiency. Because cortisol follows a diurnal rhythm, timing of the test matters significantly. A single morning serum cortisol gives a snapshot, while a 4-point salivary cortisol test across the day gives a far more complete picture of the daily cortisol curve and is preferred by integrative and functional medicine practitioners for PCOS management.

A protein produced by the liver that binds to sex hormones and renders them inactive. Low SHBG means more free testosterone is circulating, worsening androgen symptoms. Insulin resistance suppresses SHBG, which is one reason insulin resistance amplifies androgen-related symptoms in PCOS.

The skin is the largest organ in the body and is highly sensitive to hormonal signals, making it one of the most visible indicators of hormonal health. Androgen receptors are densely concentrated in the skin of the face, chest, and back, which is why elevated androgens in PCOS produce acne, oily skin, and hirsutism in precisely these areas. The sebaceous glands (oil-producing glands) are directly regulated by androgens, particularly DHT, which increases sebum production and promotes the comedone formation and bacterial environment that drives acne. The skin is also a site of active hormone conversion, containing 5-alpha reductase enzymes that convert testosterone to DHT locally, meaning androgenic skin symptoms can occur even when blood androgen levels are only mildly elevated. Beyond androgens, the skin is a major site of Vitamin D synthesis when exposed to UVB radiation, and it reflects the status of thyroid hormones (dry or dull skin in hypothyroidism), progesterone (moisture and elasticity in the luteal phase), and oestrogen (collagen density and skin thickness).

Sleep is one of the most underutilised therapeutic tools in PCOS management. During sleep, the body regulates insulin sensitivity, produces growth hormone, consolidates the circadian rhythm of cortisol, and restores the hormonal signalling that governs ovulation. Even a single night of poor sleep measurably worsens insulin resistance the following day. Chronic sleep deprivation elevates cortisol, increases hunger hormones (ghrelin), reduces satiety hormones (leptin), worsens mood and cognitive function, and suppresses ovulation. Women with PCOS are at elevated risk of sleep disturbances including insomnia, restless legs, and sleep apnoea. Progesterone deficiency, common in PCOS, reduces the brain's allopregnanolone levels, impairing the GABA system that facilitates sleep onset and deep sleep. Prioritising 7 to 9 hours of quality sleep, maintaining consistent sleep and wake times, reducing blue light exposure in the evening, keeping the bedroom cool and dark, and addressing underlying sleep apnoea are all evidence-based interventions with direct hormonal and metabolic benefits in PCOS.

Obstructive sleep apnoea (OSA) is a condition in which the upper airway repeatedly collapses during sleep, causing breathing to stop and start throughout the night. It is associated with loud snoring, gasping during sleep, unrefreshing sleep, daytime fatigue, and morning headaches. Women with PCOS have a 5 to 30 times higher prevalence of sleep apnoea than women without PCOS, even after accounting for body weight. The elevated androgen levels in PCOS appear to directly affect upper airway muscle tone and respiratory control. Sleep apnoea in turn worsens insulin resistance, elevates cortisol, increases cardiovascular risk, and perpetuates the hormonal dysfunction of PCOS. It is significantly underdiagnosed in women, who often present with more subtle symptoms than the classic male pattern. Women with PCOS who experience persistent fatigue despite adequate sleep time should raise the possibility of sleep apnoea with their doctor.

Spearmint tea has emerged in recent years as one of the more interesting and accessible anti-androgenic interventions supported by clinical evidence. Two randomised controlled trials have demonstrated that drinking two cups of spearmint tea daily significantly reduces free and total testosterone levels in women with PCOS, with one trial showing measurable reductions in hirsutism after 30 days. The mechanism appears to involve inhibition of 5-alpha reductase activity and direct anti-androgenic effects at the receptor level. Spearmint is not a pharmaceutical intervention and results are modest compared to medications like spironolactone, but as a gentle, accessible, low-risk daily practice it is a meaningful complement to a broader PCOS protocol. Spearmint tea is distinct from peppermint tea, which does not have the same evidence base.

A specialist physician, also called an internist, is a medical doctor who has completed postgraduate training in internal medicine, meaning the diagnosis and non-surgical management of complex diseases affecting the organ systems. In the context of PCOS, a specialist physician may be involved when metabolic syndrome, cardiovascular risk, diabetes, or autoimmune conditions are significant concerns. They bridge the gap between the GP and more narrow specialists like endocrinologists, taking a whole-body systems view of a patient's health. In South Africa, physicians are registered with the HPCSA and are a valuable resource when PCOS presents with significant metabolic complexity.

Spironolactone is an aldosterone antagonist and potassium-sparing diuretic that has significant anti-androgenic effects, making it widely used in PCOS for managing hirsutism, acne, and androgenic hair loss. It works by blocking androgen receptors and inhibiting androgen production, reducing the ability of testosterone and DHT to act on androgen-sensitive tissues. It is not a contraceptive but must be used with reliable contraception in women of reproductive age because it carries a risk of feminising a male fetus if pregnancy occurs. Common side effects include increased urination, electrolyte changes (particularly elevated potassium), menstrual irregularity, and breast tenderness. It is typically prescribed at doses between 50mg and 200mg daily and results in androgenic symptoms are usually visible within 3 to 6 months.

Chronic psychological and physiological stress is both a consequence and a driver of PCOS, and its impact on the condition is profound and underappreciated. Stress activates the HPA axis, elevating cortisol, which directly suppresses GnRH pulsatility (disrupting ovulation), raises blood sugar, promotes central fat storage, stimulates adrenal androgen production, increases intestinal permeability, and worsens insulin resistance. Women with PCOS also tend to have a more reactive stress response due to the neurosteroid effects of progesterone deficiency, as low progesterone means less allopregnanolone, the brain's natural calming compound. The relationship becomes cyclical: PCOS causes stress through its symptoms and challenges, and stress worsens PCOS through its physiological effects. Stress management is therefore not a soft add-on to PCOS treatment but a core therapeutic priority. Evidence-based approaches include regular mindfulness practice, yoga and restorative movement, breathwork, adequate sleep, setting boundaries around overcommitment, and targeted adaptogenic and magnesium supplementation.

This is one of the most important distinctions in women's hormonal health and one of the least discussed. Synthetic hormones, including the ethinylestradiol and progestins found in most contraceptives and older forms of HRT, are structurally different from the hormones the human body produces. They are manufactured molecules designed to mimic some hormonal effects but they do not bind to all the same receptors, do not produce the same downstream biological effects, and are metabolised differently. Bioidentical hormones are molecules that are structurally identical to the hormones produced by the human body, including oestradiol, progesterone, and testosterone. Because they are identical in structure to endogenous hormones, they interact with receptors in the same way and produce the same downstream effects. Natural progesterone, for example, supports sleep, reduces anxiety, and protects the endometrium. Synthetic progestins do not reliably replicate these effects and some actively oppose them. The difference matters profoundly for women with PCOS, who are already navigating a complex hormonal landscape. Understanding whether a medication or supplement contains synthetic or bioidentical hormones, and what the specific compound is, is one of the most empowering questions a woman can ask her doctor.

The total amount of cholesterol in the blood, including all fractions. In isolation it has limited clinical value, but it provides the baseline for calculating the TC/HDL ratio, which is a more meaningful predictor of cardiovascular risk. Women with PCOS have elevated rates of dyslipidaemia driven by insulin resistance.

One of the most clinically meaningful cardiovascular risk markers. A ratio below 4.0 is considered healthy; above 5.0 signals significant risk. The TC/HDL ratio captures the balance between harmful and protective cholesterol far better than total cholesterol alone. It is included in Dr Cooper's biochemistry panel as a core cardiovascular risk marker.

Although often thought of as a male hormone, testosterone is produced in smaller amounts by the female ovaries and adrenal glands and plays important roles in libido, energy, and muscle maintenance. In PCOS, the ovaries overproduce testosterone in response to high LH levels and insulin, driving symptoms like acne, hirsutism, and scalp hair loss.

The combined oral contraceptive pill contains synthetic versions of both oestrogen and progesterone, called ethinylestradiol and a progestin respectively. It works by suppressing the hypothalamic-pituitary-ovarian axis, essentially switching off the brain's communication with the ovaries so that FSH and LH are not released, ovulation does not occur, and the cervical mucus thickens to prevent sperm penetration. It is one of the most commonly prescribed treatments for PCOS, primarily because it regulates bleeding and reduces androgenic symptoms like acne and hirsutism. However, it is important to understand that it does not treat the underlying PCOS. It masks symptoms by overriding the hormonal system entirely. When the pill is stopped, PCOS symptoms typically return, often intensely in what is commonly called post-pill syndrome. The synthetic hormones in the pill are not equivalent to the body's own hormones. They do not produce the same downstream effects, do not support the same receptor pathways, and are processed differently by the body. Long-term use is associated with depletion of key nutrients including B vitamins, zinc, magnesium, and CoQ10, suppression of SHBG that can persist after stopping, alterations to the gut microbiome, and in some women a prolonged return to natural ovulation. For women with PCOS specifically, the pill addresses none of the metabolic, insulin-related, or inflammatory drivers of the condition.

The estrobolome is the collection of gut bacteria specifically capable of metabolising oestrogens. After the liver conjugates used oestrogens and packages them for excretion into the gut via bile, certain bacteria in the gut produce an enzyme called beta-glucuronidase that can cleave the conjugate apart, releasing free oestrogen back into circulation to be reabsorbed into the bloodstream. This bacterial recycling of oestrogen is a critical but largely unrecognised driver of oestrogen dominance. When the gut microbiome is diverse and balanced, beta-glucuronidase activity is regulated and oestrogen clearance proceeds efficiently. When dysbiosis is present, as it commonly is in women with PCOS, beta-glucuronidase activity can increase substantially, reactivating far more oestrogen than the body intended to excrete and contributing to oestrogen excess. Calcium D-Glucarate works by inhibiting beta-glucuronidase, supporting the liver's oestrogen packaging to proceed to excretion without bacterial interference. Supporting a diverse gut microbiome through dietary fibre, fermented foods, and prebiotic-rich plants is therefore directly relevant to oestrogen balance, not just digestion.

The hormones covered in this glossary represent the ones most directly relevant to PCOS, endometriosis, PMDD, adenomyosis, perimenopause, and menopause. They are, however, not the complete picture. The human body produces over 50 identified hormones, and science continues to discover new signalling molecules and hormonal interactions. Other hormones with meaningful but more indirect roles in female health include oxytocin (the bonding and trust hormone, also involved in uterine contractions and gut motility), serotonin (over 90% produced in the gut, profoundly affects mood, appetite, and pain sensitivity across the menstrual cycle), dopamine (motivation, reward, and prolactin regulation), histamine (fluctuates across the menstrual cycle and is elevated in oestrogen dominance, driving symptoms like migraines, skin reactions, and bloating), and ghrelin (the hunger hormone, elevated by poor sleep and stress). What this glossary aims to convey is not an exhaustive encyclopaedia of endocrinology but a genuinely useful map of the hormonal landscape that shapes the conditions most commonly affecting women. Every hormone in this section interacts with others. None acts in isolation. The goal is not to memorise each one but to develop an intuitive understanding of the system as a whole, so that symptoms make sense, conversations with practitioners become more informed, and the choices made every day around food, sleep, movement, and stress feel connected to something real and meaningful.

The mini pill contains only a synthetic progestogen and no oestrogen, making it suitable for women who cannot tolerate oestrogen-containing contraceptives. It works primarily by thickening cervical mucus to prevent sperm from reaching an egg, and in higher-dose versions by suppressing ovulation in some cycles. Unlike the combined pill it does not reliably suppress the HPO axis in all women, meaning some ovulatory activity may continue. The synthetic progestogens used in the mini pill are not equivalent to the body's natural progesterone. They do not produce the same calming, sleep-supporting, or anti-androgenic effects as bioidentical progesterone, and some progestogens have androgenic activity of their own, which can worsen acne, mood, and other androgen-related symptoms in women with PCOS. The specific progestogen used matters enormously, with some being far more androgenic than others.

The ovaries are two small almond-shaped glandular organs located on either side of the uterus, connected to it via the fallopian tubes. They serve two central functions: producing eggs (oocytes) and producing hormones. Each ovary contains hundreds of thousands of follicles at birth, each containing an immature egg, representing the total egg reserve a woman will ever have. The ovaries produce oestrogen, progesterone, testosterone, and androstenedione in quantities that change across the menstrual cycle and across the reproductive lifespan. In PCOS, the ovaries are the primary site of androgen overproduction, driven by elevated LH and high insulin stimulating the theca cells of the ovarian wall. The follicles in PCOS ovaries begin to develop in response to FSH but stall before reaching full maturity, accumulating in the cortex of the ovary and producing the characteristic ultrasound appearance of multiple small follicles arranged around the periphery, classically described as a string of pearls. Despite being at the centre of so much of PCOS, the ovaries themselves are not inherently broken. With the right hormonal and metabolic environment, they can and do resume normal function.

An inherited or acquired tendency for excessive blood clotting. Women with PCOS have elevated cardiovascular and thrombotic risk, and inherited thrombophilias such as Factor V Leiden and the prothrombin gene mutation amplify this risk significantly. Identifying thrombophilia is important before prescribing hormonal contraception and when planning pregnancy.

Thyroid disorders, particularly Hashimoto's thyroiditis (autoimmune hypothyroidism), are significantly more prevalent in women with PCOS than in the general population. The connection runs in both directions. Thyroid hormones regulate metabolism, ovulation, and sex hormone binding globulin (SHBG), and when thyroid function is impaired, it can worsen insulin resistance, disrupt ovulation, lower SHBG (raising free testosterone), cause fatigue and hair loss, and produce a clinical picture that closely mimics or overlaps with PCOS. Conversely, the chronic inflammation and immune dysregulation underlying PCOS may increase susceptibility to autoimmune thyroid disease. This is why Dr Cooper's comprehensive PCOS panel includes TSH, fT3, fT4, anti-TPO antibodies, and ATG antibodies as standard. Treating underlying thyroid dysfunction often significantly improves PCOS symptoms.

A butterfly-shaped gland located at the front of the neck that produces thyroid hormones T3 (triiodothyronine) and T4 (thyroxine), which regulate the metabolic rate of virtually every cell in the body. The thyroid influences body temperature, heart rate, energy production, weight, mood, hair growth, digestive function, and the menstrual cycle. It receives its instructions from the pituitary gland via TSH, which itself responds to TRH from the hypothalamus, making the thyroid part of the same hypothalamic-pituitary axis that governs reproductive function. In women with PCOS, thyroid dysfunction, particularly Hashimoto's thyroiditis, is significantly more common than in the general population. Even subtle thyroid underfunction that falls within the standard laboratory normal range can worsen insulin resistance, suppress ovulation, lower SHBG, and amplify every symptom of PCOS. The thyroid and ovarian axes are deeply interconnected, and no PCOS workup is complete without a full thyroid assessment.

The combined measurement of both bound and unbound testosterone in the blood. In PCOS this is often mildly elevated, though some women have symptoms with levels in the upper normal range. Always interpreted alongside free testosterone and SHBG.

Traditional Chinese Medicine is one of the world's oldest and most comprehensive systems of medicine, with a continuous clinical history spanning over 2500 years. TCM views the body as an interconnected whole governed by the balance of yin and yang, the flow of qi through meridian pathways, and the health of organ systems understood in their functional rather than purely anatomical sense. In TCM, PCOS is typically understood through patterns such as kidney deficiency, phlegm-dampness accumulation, liver qi stagnation, and blood stasis, often in combination. Treatment involves a highly individualised combination of acupuncture, herbal medicine, dietary guidance, and lifestyle practices tailored to the individual's specific pattern rather than a single diagnosis. Many of the herbs used in TCM for reproductive health overlap with those studied in Western research, including Vitex, dong quai, cyperus rotundus, and various adaptogenic and anti-inflammatory compounds. TCM and conventional medicine are increasingly being used together as complementary rather than competing approaches, and many women with PCOS find that addressing the nervous system, digestive health, and energetic patterns through TCM alongside targeted nutritional supplementation and lifestyle changes produces more complete and lasting improvement than either approach alone.

Fats circulating in the blood derived from dietary fat and excess carbohydrates. Elevated triglycerides are strongly associated with insulin resistance and are a key component of metabolic syndrome. In women with PCOS, high triglycerides alongside low HDL and high waist circumference signals significant metabolic risk. Reducing refined sugars is the most effective dietary intervention.

Measures thyroid function. Hypothyroidism can cause irregular periods, weight gain, fatigue, and hair loss, all of which overlap with PCOS. TSH is routinely included in PCOS workups to exclude thyroid dysfunction as an alternative or contributing cause.

Non-cancerous growths of muscle and fibrous tissue that develop within or on the wall of the uterus. They are the most common benign gynaecological tumour, affecting up to 70% of women by the age of 50. Many fibroids cause no symptoms at all and are discovered incidentally. When symptomatic, they cause heavy menstrual bleeding, prolonged periods, pelvic pressure, frequent urination, lower back pain, and can interfere with fertility depending on their size and location. Fibroids are oestrogen and progesterone sensitive and tend to grow during the reproductive years and shrink after menopause. Oestrogen dominance accelerates their growth, which is why dietary and lifestyle strategies that support healthy oestrogen clearance, including Calcium D-Glucarate, fibre, liver support, and reducing exposure to environmental oestrogens (xenoestrogens), are relevant for fibroid management.

A hollow, muscular, pear-shaped organ in the female pelvis that serves as the site of menstruation, implantation, and pregnancy. The uterus has three layers: the perimetrium (outer layer), the myometrium (muscular middle layer), and the endometrium (inner lining). In conditions related to PCOS, the endometrium is most frequently affected, thickening without regular shedding due to absent ovulation and low progesterone. In adenomyosis, the endometrial tissue invades the myometrium. In fibroids, benign growths develop within or around the myometrium. Understanding the uterus as a layered organ helps make sense of why different conditions produce different symptom patterns.

Vitamin B12 is essential for DNA synthesis, nerve function, red blood cell formation, and the methylation cycle. It works in close partnership with folate, and deficiency of either impairs the other's function. B12 deficiency is particularly relevant in PCOS for two reasons. First, women who have been on metformin for insulin resistance are at significantly elevated risk of B12 depletion, as metformin impairs B12 absorption in the gut. Second, women with MTHFR variants or gut absorption issues may have functional B12 insufficiency even with apparently normal serum levels. Active B12 (holotranscobalamin) is a more sensitive marker than standard serum B12 and is worth requesting when deficiency is suspected. Symptoms of B12 deficiency include fatigue, tingling or numbness, poor memory, depression, and hair loss.

Vitamin B12 is essential for DNA synthesis, nerve function, red blood cell formation, and the methylation cycle where it works in concert with folate. The form of B12 matters significantly. Methylcobalamin is the biologically active form that the body can use directly, whereas cyanocobalamin, the most common form in standard supplements, requires conversion and is less efficiently utilised, particularly in individuals with certain genetic variants. Women with PCOS who are taking metformin are at high risk of B12 depletion, as metformin impairs B12 absorption in the terminal ileum. Deficiency causes fatigue, depression, brain fog, peripheral neuropathy, and impaired methylation that worsens homocysteine levels and egg quality. Supplementing with methylcobalamin rather than cyanocobalamin ensures the most direct and reliable repletion.

The storage form of Vitamin D, used to assess overall Vitamin D status. Deficiency is extremely common in women with PCOS and is independently associated with insulin resistance, impaired ovarian function, mood disorders, and systemic inflammation. Optimal levels for PCOS management are generally considered to be above 75 nmol/L.

An herb derived from the berry of the chaste tree, used for centuries to support female hormonal balance. Vitex acts on the pituitary gland to normalise LH and FSH ratios, support progesterone production, and reduce hyperprolactinaemia. Clinical evidence supports its use for cycle irregularity, PMS, and luteal phase deficiency.

A plant containing diosgenin, a compound that can be converted into progesterone and other steroids in a laboratory setting. Wild yam creams are widely marketed as natural progesterone, but the human body cannot make this conversion on its own. Wild yam does however have mild oestrogenic activity and is sometimes used to relieve menopausal symptoms including hot flushes and vaginal dryness. As with dong quai, its oestrogenic properties make it unsuitable for oestrogen-dominant conditions including PCOS, endometriosis, PMDD, and uterine fibroids, where adding oestrogen-like compounds can amplify symptoms.

Xenoestrogens are synthetic chemical compounds found in the environment that mimic oestrogen in the body by binding to oestrogen receptors. They are found in plastics (particularly BPA and phthalates in plastic food and water containers), pesticides and herbicides on non-organic produce, synthetic fragrances and personal care products, non-stick cookware coatings, receipts and thermal paper, and conventionally raised meat and dairy containing residual hormones. Chronic exposure to xenoestrogens contributes to oestrogen dominance, disrupts hormonal signalling, impairs fertility, and may worsen PCOS, endometriosis, and other oestrogen-sensitive conditions. Reducing exposure involves choosing glass or stainless steel over plastic for food and water storage, choosing organic produce where possible, reading labels on personal care products, and filtering drinking water. Xenoestrogen elimination through the liver and gut (supported by Calcium D-Glucarate, cruciferous vegetables, and adequate fibre) is equally important.

An essential mineral critical for hormone synthesis, ovulation, and immune function. In PCOS, zinc deficiency is common and correlates with higher androgen levels and more severe acne. Zinc supplementation has been shown to reduce testosterone, improve insulin sensitivity, and reduce inflammatory markers. Not all zinc is equally absorbed. Zinc picolinate and zinc bisglycinate are the most bioavailable forms, absorbed efficiently in the gut. Zinc oxide and zinc sulfate, commonly found in cheaper supplements, are poorly absorbed and largely excreted. Some individuals also carry genetic variants in zinc transporter genes (SLC30A and SLC39A families) that further reduce absorption, making the form of zinc chosen even more clinically significant. Note that Life Source formulas do not currently contain zinc.

Zinc and copper exist in a critical balance in the body. They compete for the same absorption pathways, meaning excess of one depletes the other. In women with PCOS, zinc deficiency is common and contributes to androgen excess, poor insulin sensitivity, and immune dysfunction. Copper excess, which can occur with the copper IUD, high copper dietary intake, or oestrogen dominance (oestrogen drives copper retention), suppresses zinc and is associated with anxiety, depression, brain fog, and worsening hormonal symptoms. Testing both together gives a meaningful picture of mineral balance. Ideally serum zinc and copper, alongside hair tissue mineral analysis (HTMA), give the most complete assessment.